<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD005268" GROUP_ID="ENDOC" ID="180805022312322334" MERGED_FROM="" MODIFIED="2008-11-24 10:28:11 +0100" MODIFIED_BY="Bernd Richter" REVIEW_NO="042" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="2.2">
<COVER_SHEET MODIFIED="2008-11-24 10:28:11 +0100" MODIFIED_BY="Bernd Richter">
<TITLE>Individual patient education for people with type 2 diabetes mellitus</TITLE>
<CONTACT MODIFIED="2008-11-24 10:28:11 +0100" MODIFIED_BY="Bernd Richter"><PERSON ID="B61D325082E26AA20130726FEBDF69A7" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Ruth</FIRST_NAME><LAST_NAME>Colagiuri</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>rcolagiuri@med.usyd.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>The Diabetes Unit, Australian Health Policy Institute, School of Public Health</DEPARTMENT><ORGANISATION>University of Sydney</ORGANISATION><ADDRESS_1>Victor Coppleson Building, DO2 The University of Sydney</ADDRESS_1><CITY>Sydney </CITY><ZIP>NSW 2006</ZIP><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 2 9036 6357</PHONE_1><FAX_1>+61 2 9351 5204</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2008-11-24 10:28:11 +0100" MODIFIED_BY="Bernd Richter"><PERSON ID="BB4F2EA882E26AA200506EE7611CE264" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Sally-Anne</FIRST_NAME><MIDDLE_INITIALS>S</MIDDLE_INITIALS><LAST_NAME>Duke</LAST_NAME><POSITION>Senior Research Officer</POSITION><ADDRESS><DEPARTMENT>The Diabetes Unit, Australian Health Policy Institute, School of Public Health</DEPARTMENT><ORGANISATION>University of Sydney </ORGANISATION><CITY>Sydney </CITY><COUNTRY CODE="AU">Australia</COUNTRY></ADDRESS></PERSON><PERSON ID="4540" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Stephen</FIRST_NAME><LAST_NAME>Colagiuri</LAST_NAME><POSITION>Chair of Metabolic Health</POSITION><EMAIL_1>scolagiuri@med.usyd.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>Institute of Obesity, Nutrition and Exercise</DEPARTMENT><ORGANISATION>The University of Sydney</ORGANISATION><ADDRESS_1>K25 - Medical Foundation Building </ADDRESS_1><CITY>Sydney </CITY><ZIP>2006</ZIP><REGION>NSW</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 2 90363103</PHONE_1><FAX_1>+61 2 9036 3716</FAX_1></ADDRESS></PERSON><PERSON ID="B61D325082E26AA20130726FEBDF69A7" ROLE="AUTHOR"><PREFIX>A/Prof</PREFIX><FIRST_NAME>Ruth</FIRST_NAME><LAST_NAME>Colagiuri</LAST_NAME><POSITION>Director</POSITION><EMAIL_1>rcolagiuri@med.usyd.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>The Diabetes Unit, Australian Health Policy Institute, School of Public Health</DEPARTMENT><ORGANISATION>University of Sydney</ORGANISATION><ADDRESS_1>Victor Coppleson Building, DO2 The University of Sydney</ADDRESS_1><CITY>Sydney </CITY><ZIP>NSW 2006</ZIP><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 2 9036 6357</PHONE_1><FAX_1>+61 2 9351 5204</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2008-10-31 11:20:11 +0100" MODIFIED_BY="Bernd Richter">
<UP_TO_DATE>
<DATE DAY="30" MONTH="4" YEAR="2007"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="4" YEAR="2007"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="11" YEAR="2010"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="2" YEAR="2005"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2005"/>
</DATES>
<WHATS_NEW>
<WHATS_NEW_ENTRY EVENT="AMENDMENT">
<DATE DAY="7" MONTH="8" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-10-31 11:01:32 +0100" MODIFIED_BY="Bernd Richter"/>
<SOURCES_OF_SUPPORT MODIFIED="2008-08-12 00:52:00 +0200" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2008-08-12 00:52:00 +0200" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2008-08-12 00:52:00 +0200" MODIFIED_BY="[Empty name]">
<NAME>Austrailian Department of Health and Ageing via the Australasian Cochrane Centre</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-11-24 10:23:20 +0100" MODIFIED_BY="Bernd Richter">
<SUMMARY MODIFIED="2008-10-31 16:42:42 +0100" MODIFIED_BY="Bernd Richter">
<TITLE MODIFIED="2008-08-13 11:14:06 +0200" MODIFIED_BY="[Empty name]">Individual patient education for people with type 2 diabetes mellitus</TITLE>
<SUMMARY_BODY MODIFIED="2008-10-31 16:42:42 +0100" MODIFIED_BY="Bernd Richter">
<P>Nine studies involving 1359 participants met the inclusion criteria. Six studies compared individual education to usual care and three compared individual education to group education (361 participants). There were no long-term studies and overall the quality of the studies was not high. Individual face-to-face patient education for type 2 diabetes over a six to twelve month period did not significantly improve glycaemic control, body mass index (BMI - measure of overweight; body weight in kilogram divided through squared height in meters, kg/m<SUP>2</SUP>), blood pressure or total cholesterol in the short or medium term compared with usual care. However, there did appear to be a significant benefit of individual education on glycaemic control in a subgroup analysis of studies involving participants with a higher baseline HbA1c greater than 8% (that is, too high blood sugar levels over a couple of months or inadequate 'metabolic control'). In the studies comparing individual education to group education, there was no significant difference between individual or group education at 12 to 18 months nor a significant difference in the impact of individual education versus group education on BMI, systolic or diastolic blood pressure.</P>
<P>An exact analysis on dietary self management, diabetes knowledge, psychosocial outcomes and smoking habits could not be performed because there were limited studies and varied measurement tools. However, descriptive evaluation suggested that there was no significant difference in quality of life, self management skills or knowledge between group and individual education. When comparing individual patient education to usual care, the limited number of studies available suggested a positive outcome on self management, smoking and knowledge, however there was conflicting evidence surrounding psychosocial outcomes. No data were available on the other main outcome measures of diabetes complications or health service utilization and cost analysis in these studies.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-11-24 10:19:33 +0100" MODIFIED_BY="Bernd Richter">
<ABS_BACKGROUND MODIFIED="2008-11-21 11:15:09 +0100" MODIFIED_BY="Bernd Richter">
<P>Type 2 diabetes is a common and costly chronic disease which is associated with significant premature mortality and morbidity. Although patient education is an integral component of diabetes care, there remain uncertainties regarding the effectiveness of different methods and modes of education.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2008-11-21 11:16:17 +0100" MODIFIED_BY="Bernd Richter">
<P>To evaluate the effectiveness of individual patient education on metabolic control, diabetes knowledge and psychosocial outcomes.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-11-21 11:17:03 +0100" MODIFIED_BY="Bernd Richter">
<P>Multiple electronic bibliographic databases were searched, including <I>The Cochrane Library</I>, MEDLINE, Premedline, ERIC, Biosis, AMED, Psychinfo, EMBASE, CINAHL, APAIS-health, Australian Medical Index, Web of Science, dissertation abstracts and Biomed Central.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2008-11-21 11:18:52 +0100" MODIFIED_BY="Bernd Richter">
<P>Randomized controlled and controlled clinical trials which evaluated individual education for adults with type 2 diabetes. The intervention was individual face-to-face patient education while control individuals received usual care, routine treatment or group education. Only studies that assessed outcome measures at least six months from baseline were included.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2008-11-21 11:22:37 +0100" MODIFIED_BY="Bernd Richter">
<P>Information was extracted by two reviewers who summarized both study characteristics and outcome statistics. A meta-analysis using a fixed-effect model was performed if there were adequate studies with a specified outcome of sufficient homogeneity. For outcomes where there were too few studies or the assessment measurements were not standardized or variable, the results were summarised qualitatively.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2008-11-24 10:19:33 +0100" MODIFIED_BY="Bernd Richter">
<P>Nine studies involving 1359 participants met the inclusion criteria. Six studies compared individual education to usual care and three compared individual education to group education (361 participants). There were no long-term studies and overall the quality of the studies was not high. In the six studies comparing individual face-to-face education to usual care, individual education did not significantly improve glycaemic control (weighted mean difference (WMD) in HbA1c -0.1% (95% confidence interval (CI) -0.3 to 0.1, P = 0.33) over a 12 to 18 month period. However, there did appear to be a significant benefit of individual education on glycaemic control in a subgroup analysis of three studies involving participants with a higher mean baseline HbA1c greater than 8% (WMD -0.3% (95% CI -0.5 to -0.1, P = 0.007). In the two studies comparing individual to group education, there was no significant difference in glycaemic control between individual or group education at 12 to 18 months with a WMD in HbA1c of 0.03% (95% CI -0.02 to 0.1, P = 0.22). There was no significant difference in the impact of individual versus usual care or group education on body mass index systolic or diastolic blood pressure. There were too few studies to perform a meta-analysis on the effect of individual education on dietary self management, diabetes knowledge, psychosocial outcomes and smoking habits. No data were available on the other main outcome measures of diabetes complications or health service utilization and cost analysis in these studies.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2008-11-21 11:30:14 +0100" MODIFIED_BY="Bernd Richter">
<P>This systematic review suggests a benefit of individual education on glycaemic control when compared with usual care in a subgroup of those with a baseline HbA1c greater than 8%. However, overall there did not appear to be a significant difference between individual education and usual care. In the small number of studies comparing group and individual education, there was an equal impact on HbA1c at 12 to 18 months. Additional studies are needed to delineate these findings further.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-11-24 10:23:20 +0100" MODIFIED_BY="Bernd Richter">
<BACKGROUND MODIFIED="2008-11-12 18:12:58 +0100" MODIFIED_BY="Bernd Richter">
<CONDITION MODIFIED="2008-11-12 16:45:17 +0100" MODIFIED_BY="Bernd Richter">
<P>Diabetes mellitus is a disorder in the metabolism of blood glucose. It occurs when the body no longer responds effectively to endogenous insulin or when the body's production of insulin is inadequate. This leads to chronic hyperglycaemia (elevated levels of plasma glucose) accompanied by abnormal metabolism of carbohydrate, fat and protein. In the long term, people with diabetes are predisposed to complications which include retinopathy, nephropathy and neuropathy. The risk of cardiovascular disease is also substantially increased. For a detailed overview of diabetes mellitus, please see under 'Additional information' in the information on the Metabolic and Endocrine Disorders Group in <I>The Cochrane Library </I>(see 'About', 'Cochrane Review Group (CRGs)'). For an explanation of methodological terms, see the main glossary in <I>The Cochrane Library</I>.</P>
<P>Type 2 diabetes is one the commonest chronic diseases globally and is closely entwined with the obesity epidemic. The International Diabetes Federation reported an estimate of 194 million people with diabetes in 2003 and predicted that this will increase to 333 million in 2025 (<LINK REF="REF-Diabetes-Atlas-2005" TYPE="REFERENCE">Diabetes Atlas 2005</LINK>) and similar projections have been made by the World Health Organization (<LINK REF="REF-Wild-2004" TYPE="REFERENCE">Wild 2004</LINK>). Most of the increase in diabetes prevalence is predicted to occur in the developing countries where by 2025 more than 75% of the people with diabetes under the age of 65 will reside (<LINK REF="REF-King-1998" TYPE="REFERENCE">King 1998</LINK>). Hence, in addition to the direct disease costs, diabetes will place an enormous additional burden on these countries through productivity losses. The financial cost of diabetes is immense and increasing. The national costs of diabetes for 2002 in the US is estimated at US$ 92 billion to US$ 132 billion (approx. 72 to 103 billion EUROS) in direct medical expenditure and US$ 40 billion (approx. 31 billion EUROS) for indirect costs and is estimated to increase to US $192 billion (approx. 150 billion EUROS) in 2020 (<LINK REF="REF-ADA-2003" TYPE="REFERENCE">ADA 2003</LINK>). Complications are the main driver of all types of diabetes costs increasing the annual cost of diabetes in Australia from US$ 3220 (2523 EUROS) in people without complications to US$ 7715 (6044 EUROS) for people with both microvascular and macrovascular complications. European studies, ie CODE-2 (<LINK REF="REF-Jonsson-2002" TYPE="REFERENCE">Jonsson 2002</LINK>) and the UK T2ARDIS study (<LINK REF="REF-Holmes-2003" TYPE="REFERENCE">Holmes 2003</LINK>) showed similar effects with quality of life glycaemic average scores also significantly reduced by complications.</P>
</CONDITION>
<INTERVENTION MODIFIED="2008-11-12 18:12:58 +0100" MODIFIED_BY="Bernd Richter">
<P>These findings demonstrate the high financial burden associated with diabetes and its complications that may, a least in part, be attributable to deficiencies in self management. Education that increases patients' understanding of diabetes can prevent or delay complications and reduce the number and duration of hospitalisations, which in turn can improve quality of life glycaemic. Different methods of teaching people self-management practices may affect long-term compliance, relative to many other conditions, the impact of self-management on diabetes outcomes is important not only to the individual but to the community in the form of health care costs (<LINK REF="REF-Glasgow-1999" TYPE="REFERENCE">Glasgow 1999</LINK>). In the USA it has been found that medical non-compliance in people with type 2 diabetes imposes a financial burden in the order of 100 billion dollars (approx. 78 billion EUROS) each year (<LINK REF="REF-Vermeire-2003" TYPE="REFERENCE">Vermeire 2003</LINK>). Consequently, patient education is recognized globally as an essential component of diabetes management but its relationship to health outcomes and health service utilization is still not well understood (<LINK REF="REF-Corabian-2001" TYPE="REFERENCE">Corabian 2001</LINK>; <LINK REF="REF-Ellis-2004" TYPE="REFERENCE">Ellis 2004</LINK>; <LINK REF="REF-Loveman-2008" TYPE="REFERENCE">Loveman 2008</LINK>) and reports of its effectiveness are variable (<LINK REF="REF-Loveman-2008" TYPE="REFERENCE">Loveman 2008</LINK>). Nonetheless, due to the onerous requirements for self-care that demands multiple daily decisions in order to balance diet, physical activity and medications, it is widely accepted that diabetes education is not only required in the first few months following diagnosis but is an important component of ongoing diabetes care (<LINK REF="REF-Loveman-2003" TYPE="REFERENCE">Loveman 2003</LINK>). The question, then, is not so much about whether or not people with diabetes should have diabetes education but about which methods and models of education produce the best effect on behaviour change, self management, and physical and psychological outcomes.</P>
<P>An important Health Technology Assessment on patient education for type 2 diabetes by Corabian and Harstall (<LINK REF="REF-Corabian-2001" TYPE="REFERENCE">Corabian 2001</LINK>) points out that a particular difficulty in assessing educational interventions is the lack of well defined long-term outcomes, and this is supported by Loveman et al (<LINK REF="REF-Loveman-2008" TYPE="REFERENCE">Loveman 2008</LINK>). However, since then the American Association of diabetes educators has published criteria for behaviour change as a result of education (<LINK REF="REF-AADE-2003" TYPE="REFERENCE">AADE 2003</LINK>) and Australia has developed a national consensus on outcomes and indicators for diabetes patient education (<LINK REF="REF-Eigenmann-2007" TYPE="REFERENCE">Eigenmann 2007</LINK>). Patient empowerment, as championed by <LINK REF="REF-Funnell-2004" TYPE="REFERENCE">Funnell 2004</LINK> has been gathering popularity as an educational model since the 1980s and has been shown to produce benefits such as improved communication with providers, greater satisfaction with care, improvements in metabolic and psychological outcomes and quality of life. More recent education models such as Diabetes X-PERT (<LINK REF="REF-Deakin-2006" TYPE="REFERENCE">Deakin 2006</LINK>) and DESMOND (<LINK REF="REF-Davies--2008" TYPE="REFERENCE">Davies 2008</LINK>) are representative of current efforts to better define, structure and evaluate the effect of diabetes education. However, these reports, like the majority of research reports in the peer reviewed literature about diabetes patient education focus on group education. A systematic review by Norris and colleagues (<LINK REF="REF-Norris-2001" TYPE="REFERENCE">Norris 2001</LINK>) found evidence that self management training in people with type 2 diabetes was effective. Despite inclusions of some studies assessing individual patient education, the majority of studies included in the review focused on group education. A Cochrane Review by Deakin and colleagues (<LINK REF="REF-Deakin-2005" TYPE="REFERENCE">Deakin 2005</LINK>) also concluded that adults with type 2 diabetes improved diabetes control and knowledge of diabetes after group-based training programmes.</P>
</INTERVENTION>
<IMPORTANCE MODIFIED="2008-10-31 11:39:47 +0100" MODIFIED_BY="Bernd Richter">
<P>Individual education is a common form of patient education for people with diabetes but, to date, there has been no formal review of the effects of individual patient education on outcomes in people with type 2 diabetes. The availability of this information is critical to informing service and resource allocation decisions relating to individual patient education.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2008-10-31 13:02:03 +0100" MODIFIED_BY="Bernd Richter">
<P>To evaluate the effects of individual face-to-face patient education.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-11-19 16:38:16 +0100" MODIFIED_BY="Bernd Richter">
<SELECTION_CRITERIA MODIFIED="2008-11-19 16:38:16 +0100" MODIFIED_BY="Bernd Richter">
<CRIT_STUDIES MODIFIED="2008-10-31 14:22:44 +0100" MODIFIED_BY="Bernd Richter">
<P>Only randomised controlled trials and controlled clinical trials were included.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2008-11-12 17:43:48 +0100" MODIFIED_BY="Bernd Richter">
<P>Participants were adults diagnosed with type 2 diabetes over the age of 18 years. To be consistent with changes in classification and diagnostic criteria of the disease through the years, the diagnosis should have been established using the standard criteria valid at the time of beginning the study. These diagnostic criteria included those described by the World Health Organisation (<LINK REF="REF-WHO-1980" TYPE="REFERENCE">WHO 1980</LINK>; <LINK REF="REF-WHO-1985" TYPE="REFERENCE">WHO 1985</LINK>; <LINK REF="REF-WHO-1998" TYPE="REFERENCE">WHO 1998</LINK>) and the American Diabetes Association Standards (<LINK REF="REF-ADA-1999" TYPE="REFERENCE">ADA 1999</LINK>). The review excluded interventions specific for maturity onset diabetes of the young (MODY) or women with gestational diabetes.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-10-31 14:38:22 +0100" MODIFIED_BY="Bernd Richter">
<P>This review only included studies where individual patient education formed the major component of the intervention. If the study included both individual and group education then it was included only if the individual component was a systematic programme designed for individual education. Studies were restricted to those that reported outcomes at six months from baseline or later.</P>
<P>Individual patient education that met the following criteria:<BR/>
</P>
<UL>
<LI>was specific for people with type 2 diabetes;</LI>
<LI>was face-to-face (not telephone- or computer-based);</LI>
<LI>education addressed a wide range of self-management issues and was not limited to particular aspects such as weight management, physical activity or foot care;</LI>
<LI>aimed to impact on clinical outcomes and/or health service utilisation and costs.</LI>
</UL>
<P>
<BR/>The intervention group was compared with those who received:<BR/>
</P>
<UL>
<LI>group education;</LI>
<LI>no specific intervention;</LI>
<LI>usual care (receiving the standard care such as regular follow up with the health provider).</LI>
</UL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-11-19 16:38:16 +0100" MODIFIED_BY="Bernd Richter">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-11-19 16:38:16 +0100" MODIFIED_BY="Bernd Richter">
<UL>
<LI>metabolic control, measured by glycated haemoglobin A1c (HbA1c);</LI>
<LI>diabetes complications (eg retinopathy, nephropathy, neuropathy, lower limb amputation, cardiovascular disease);</LI>
<LI>health service utilisation and health care costs (admission and readmission rates, average length of stay, visits to the general practitioner and the emergency department).</LI>
</UL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-10-31 14:40:12 +0100" MODIFIED_BY="Bernd Richter">
<UL>
<LI>psychosocial outcomes (quality of life, psychological problems such as depression);</LI>
<LI>diabetes knowledge;</LI>
<LI>patient self-care behaviours (dietary habits, physical activity levels) or self management skills (medication administration, use of equipment);</LI>
<LI>physical measures (body mass index (BMI, kg/m<SUP>2</SUP>), weight (kg), blood pressure (systolic and diastolic (mmHg));</LI>
<LI>metabolic (lipids - total cholesterol (mmol/L), HDL cholesterol (mmol/L), LDL cholesterol (mmol/L), triglycerides (mmol/L)).</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="5">Timing of outcome measurement</HEADING>
<P>Outcomes were assessed in the short (6 to 9 months), the medium term (12 to 18 months) and longer term (greater than 18 months).</P>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-11-12 17:13:05 +0100" MODIFIED_BY="Bernd Richter">
<ELECTRONIC_SEARCHES MODIFIED="2008-11-12 17:12:54 +0100" MODIFIED_BY="Bernd Richter">
<P>The following electronic databases were searched from the date on which records began up until April 2007: <I>The Cochrane Library</I>, MEDLINE, Premedline, ERIC, Biosis, AMED, Psychinfo, EMBASE, CINAHL, APAIS-health, Australian Medical Index, Web of Science, dissertation abstracts and Biomed Central. Studies published in any language were included.</P>
<P>The MEDLINE search strategy can be viewed in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. The other databases were searched with a similar strategy adjusted for the particular database.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-11-12 17:12:05 +0100" MODIFIED_BY="Bernd Richter">
<STUDY_SELECTION MODIFIED="2008-11-12 17:10:36 +0100" MODIFIED_BY="Bernd Richter">
<P>Following removal of obviously irrelevant studies, reviews or duplicates by a single reviewer (SD), two independent reviewers (SD, RC) scanned the title and abstract and keywords of every record and retrieved the full text for further assessment when the reference suggested that the study may fit the inclusion criteria. The full text of these studies was analysed and identified as included or excluded independently by three reviewers (SD, RC, SC) based on the above inclusion criteria. Any differences of opinion were discussed and an agreement reached through consensus. In one case the authors were contacted to assist in clarification. Only original published studies were considered.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2008-10-31 14:43:00 +0100" MODIFIED_BY="Bernd Richter">
<P>Information was extracted from each reference into a template developed by the authors and presented under <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>. The following information was extracted:</P>
<P>1. Methods: location, method of recruitment including clinical setting, inclusion, exclusion criteria, allocation, blinding, permission, power analysis, intention-to-treat.<BR/>2. Participants: baseline data, sample size, attrition rate, baseline HbA1c and duration of diabetes.<BR/>3. Intervention: description of education given to intervention participants and control participants.<BR/>4. Outcome: variables and their measures.<BR/>5. Allocation concealment: one of four categories.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2008-11-12 17:10:52 +0100" MODIFIED_BY="Bernd Richter">
<P>Each study was assessed individually for methodological quality and analyzed particularly for potential sources of bias by two reviewers (SD, SC). The following factors were assessed:<BR/>a) Minimization of selection bias - was there adequate randomization and allocation concealment?<BR/>b) Minimization of attrition bias - were withdrawals and dropouts completely described and was analysis by intention-to-treat?<BR/>c) Minimization of Detection bias - were outcome assessors blind to the interventions?</P>
<P>The trials were then summarized into three categories as described in <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2005" TYPE="REFERENCE">Higgins 2005</LINK>).</P>
<P>A Low risk of bias where all the criteria were met<BR/>B Moderate risk of bias were one or more criteria were partly met<BR/>C High risk of bias where one or more criteria were not met</P>
</QUALITY_ASSESSMENT>
<HETEROGENEITY_ASSESSMENT MODIFIED="2008-11-12 17:11:14 +0100" MODIFIED_BY="Bernd Richter">
<P>Variation between studies (heterogeneity) was investigated using the I<SUP>2</SUP>-statistic, which describes the percentage of total variation across studies that is due to heterogeneity rather than chance. It allows for calculation and comparison across studies of varying sizes, study types and with varying outcome data (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>).</P>
<P>When outcome measurements were not significantly homogeneous for meta-analysis (such as use of non standardized questionnaires or variable measurement tools) or if there were inadequate number of studies, then they were summarized in a qualitative manner.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2008-11-12 17:11:44 +0100" MODIFIED_BY="Bernd Richter">
<P>Data were summarized statistically only if there were adequate numbers of studies with sufficient homogeneity and quality. For continuous variables, analysis was based on mean change from baseline and using the weighted mean difference. When standard deviations were not presented they were derived from standard errors, confidence intervals or probability values when available. A meta-analysis using a fixed-effect model was performed if there were adequate studies with sufficient homogeneity.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2008-10-31 12:39:36 +0100" MODIFIED_BY="Bernd Richter">
<P>Where data were available, subgroup analyses were performed on the effects of individual education and the influences of gender, ethnic background, baseline HbA1c, duration of diabetes and contact time.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2008-11-12 17:12:05 +0100" MODIFIED_BY="Bernd Richter">
<P>We planned to perform sensitivity analyses in order to explore the influence of the following factors on effect size:</P>
<UL>
<LI>repeating the analysis excluding unpublished studies;</LI>
<LI>repeating the analysis taking account of study quality, as specified above;</LI>
<LI>repeating the analysis excluding any very long or large studies to establish how much they dominate the results;</LI>
<LI>repeating the analysis excluding studies using the following filters: diagnostic criteria, language of publication, source of funding (industry versus other), country.</LI>
</UL>
<P>The robustness of the results was also planned to be tested by repeating the analysis using different measures of effects size (risk difference, odds ratio etc.) and different statistical models (fixed- and random-effects models).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-11-24 10:23:20 +0100" MODIFIED_BY="Bernd Richter">
<STUDY_DESCRIPTION MODIFIED="2008-11-19 16:38:18 +0100" MODIFIED_BY="Bernd Richter">
<SEARCH_RESULTS MODIFIED="2008-11-12 17:14:55 +0100" MODIFIED_BY="Bernd Richter">
<P>The electronic databases cited above were searched from the date on which records began up until April 2007. Search strategies were designed to capture references that observed any effect of individual patient education as one of the interventions. From the initial search 8235 citations were identified from the following databases, <I>The Cochrane Library</I> (351), MEDLINE (1781), Premedline (203), ERIC (24), Biosis (379), AMED (20), Psychinfo (92), EMBASE (3317), CINAHL (703), APAIS-health (20), Australian Medical Index (306), Web of science (511), Dissertation abstracts (440) and Biomed central (88). These references were scanned by one reviewer and 7883 were removed because they were obviously irrelevant studies, reviews or duplicates. The search resulted in a total of 352 identified potentially relevant references. The abstracts were studied in detail and full references when necessary by two independent reviewers. Abstracts were required to be translated in four Chinese papers and three Spanish papers. Nine studies completely fulfilled the inclusion criteria ( (see <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> for details of the amended QUOROM (quality of reporting of meta-analyses) flow-chart of study selection, <LINK REF="REF-Moher-1999" TYPE="REFERENCE">Moher 1999</LINK>). There was consensus among the three reviewers. All publications were in English except for one which was in Spanish (<LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK>) for which data were extracted from translated information.</P>
<P>The main reasons for exclusion were (see details of excluded studies for further information):<BR/>
</P>
<UL>
<LI>the trial focused on group education or contained components of group education;</LI>
<LI>was not a randomised or controlled clinical trial;</LI>
<LI>education was not face-to-face;</LI>
<LI>the study focused on patient participation or case management rather than education;</LI>
<LI>education was for a specific issue such as foot care, weight loss or physical activity.</LI>
</UL>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2008-11-19 16:38:18 +0100" MODIFIED_BY="Bernd Richter">
<P>A total of nine studies met the inclusion criteria. Six compared individual education to usual care (<LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK>; <LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK>; <LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>; <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>; <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>) and three compared individual education to group education (<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK>; <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>). There were no long-term studies. Three trials were carried out in the United States, one in Australia, one in Spain, one in the Netherlands, one in Japan, one in Hong Kong and one in the United Kingdom. The included studies appeared in the following publications, with frequency shown in brackets.<BR/>
</P>
<UL>
<LI>Atencion Primaria (1)</LI>
<LI>British Journal of General Practice (1)</LI>
<LI>Diabetes Care (2)</LI>
<LI>Diabetes Educator (2)</LI>
<LI>Diabetes Research and Clinical Practice (1)</LI>
<LI>Diabetic Medicine (2)</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="4">Study Design</HEADING>
<P>All included studies were randomized controlled studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>The included studies involved 1359 participants. The smallest study had 53 participants (<LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>) and the largest study had 376 participants (<LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK>). All trials except one (<LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>) recruited both men and women. The mean age of the participants was between 52 to 65 years. One study focused on education in a migrant population with a low level of literacy (<LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK>). The duration of diabetes prior to the study was quite variable, with three studies reporting a duration of greater than seven years (<LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK>; <LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK>; <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>), four studies where the duration of diabetes was less than three years (<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK>, <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>; <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>) and two studies where it was not stated (<LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>). The HbA1c level at the commencement of the study was also quite variable ranging from 6.6% to 12.2%. See <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> for further information.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions</HEADING>
<P>The criteria for inclusion demanded that the majority of the intervention involved face-to-face education and covered a wide range of diabetes related topics. The content of the education typically covered pathophysiology of diabetes, diabetes control through diet, diabetes control through exercise, compliance with medication, exercise and exercise regimes, glucose self-monitoring, diabetic complications, foot care, services available, motivation and behavioural strategies. The total face-to-face time varied considerably as did the frequency of the sessions and the number of months it was carried over. Most studies involved 2 to 4 hours of face-to-face time (<LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK> (2.5 hrs), <LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK> (4 hrs), <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK> (2.5 hrs), <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK> (3 hrs), <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK> (approx. 3 hrs). Two studies contained less 2 hours or less of contact time (<LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK> (2 hours), <LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK> (20 min sessions) and two studies involved greater than five hours of contact time (<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK> (approx. 7 hrs), <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK> (5 to 7 hrs). The majority of the interventions were carried out by diabetes educators and dieticians. One study (<LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK>) trained a link worker, who had no previous medical background, to carry out the education.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcome measures</HEADING>
<P>Only a limited number of outcomes were assessed in these nine studies. The main outcomes common to most studies were glycaemic control and basic physical measures. The studies were too short to assess complications and a cost effectiveness analysis was not covered by any of the studies.</P>
<SUBSECTION>
<HEADING LEVEL="5">Primary outcomes</HEADING>
<UL>
<LI>metabolic control, measured by glycated haemoglobin A1c (HbA1c): all studies assessed HbA1c;</LI>
<LI>diabetes complications: none assessed this outcome;</LI>
<LI>health service utilisation and health care costs: none assessed this outcome.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Secondary outcomes</HEADING>
<UL>
<LI>psychosocial outcomes: <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>; <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>; <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>,</LI>
<LI>diabetes knowledge: <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK>; <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>;</LI>
<LI>patient self-care behaviours or self management skills : <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>; <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>;</LI>
<LI>physical measures (body mass index or blood pressure): <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK>; <LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>; <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>; <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>; <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>;</LI>
<LI>metabolic (lipids): <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK>; <LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>; <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>.</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-11-12 17:18:01 +0100" MODIFIED_BY="Bernd Richter">
<BLINDING MODIFIED="2008-10-31 15:49:36 +0100" MODIFIED_BY="Bernd Richter">
<P>In this type of intervention blinding of participants is not possible. Blinding of physicians was reported in <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK> and <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2008-10-31 15:50:44 +0100" MODIFIED_BY="Bernd Richter">
<P>Loss to follow-up was quite variable with some studies suffering significant loss to follow-up. These included <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK> (64% loss to follow-up at 12 months) and <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK> (46% loss to follow-up at six months). Those with minimal loss to follow-up included <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK> (1% loss to follow-up) and <LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK> (5% loss to follow-up at six months). The other studies had reasonable follow-up; <LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK> (14% loss to follow-up at 12 months), <LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK> (14% loss to follow-up 18 months), <LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK> (16% loss to follow-up at 12 months), <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK> (10% loss to follow-up at 12 months) and <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK> (8% loss to follow-up at six months).</P>
</EXCLUSIONS>
<OTHER_BIAS_SOURCES MODIFIED="2008-11-12 17:18:01 +0100" MODIFIED_BY="Bernd Richter">
<P>Four studies presented a power calculation to detect a difference in HbA1c between the intervention groups (<LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK>; <LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK> and <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2008-11-24 10:23:20 +0100" MODIFIED_BY="Bernd Richter">
<SUBSECTION>
<HEADING LEVEL="3">Data analysis</HEADING>
<P>Mean change from baseline was compared in the short term (6 to 9 months) and medium term (12 to 18 months). No long-term studies fitted the inclusion criteria. The analysis was divided to compare individual to usual care (<LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK>; <LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK>; <LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>; <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>; <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>) and individual education to group education (<LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK>; <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>).</P>
<P>There were four interventions (minimal, extensive group, extensive individual and behavioural) in the study of <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>. However, as the minimal group was only a six month evaluation it was decided to restrict the analysis to individual versus group education.</P>
<P>When standard deviations were not presented they were derived from standard errors, confidence intervals or probability values when available. These conversion methods to obtain standard deviations of the change from baseline are described in the <I>Cochrane Handbook for Systematic Reviews of Interventions </I>(<LINK REF="REF-Higgins-2005" TYPE="REFERENCE">Higgins 2005</LINK>).</P>
<P>In some studies, the standard deviation of the change from baseline was unavailable (<LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK>; <LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>). It was therefore necessary to calculate this using the baseline and final standard deviations with an estimation of the correlation coefficient. There were inadequate data to estimate this from the available studies and therefore an imputed correlation coefficient value of 0.75 was thought to be a reasonable estimate for most outcome variables. A separate analysis using a correlation coefficient of 0.25 was also applied to the analysis of HbA1c as a more conservative estimation of this variable.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Heterogeneity</HEADING>
<P>A &#967;<SUP>2</SUP>-test for heterogeneity was performed for each outcome using the I<SUP>2</SUP>-statistic and is reported below. The majority of the analyses showed non-substantial heterogeneity (less than 50%).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Glycated haemoglobin A1c (HbA1c)</HEADING>
<P>All nine studies assessed HbA1c, five studies reported data for 6 to 9 months and seven studies reported 12 to 18 month data.</P>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus usual care</HEADING>
<P>Three studies involving 295 participants assessed HbA1c at 6 to 9 months (<LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK>; <LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK>; <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>). The weighted mean difference (WMD) in HbA1c at 6 to 9 months was -0.2% with a trend to favour individual patient education, however this did not reach significance (95% confidence interval (CI) -0.5 to 0.03, P = 0.08). Heterogeneity was low (I<SUP>2</SUP> = 15.6%).</P>
<P>Four studies involving 632 participants assessed HbA1c at 12 to 18 months (<LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK>; <LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>; <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>). There was relatively low heterogeneity (I<SUP>2</SUP> = 30.7%). There was no significant difference in improvement in HbA1c following patient education with the WMD in HbA1c: -0.1% (95% CI -0.3 to 0.1, P = 0.33).</P>
<P>Changing the correlation coefficient to r = 0.25 did not substantially change the outcome. The WMD in HbA1c at 6 to 9 months was -0.3% (95% CI -0.7 to 0.2) and 12 to 18 months -0.1% (95% CI -0.3 to 0.1).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus group education</HEADING>
<P>Only two studies looked at individual education versus group education at 6 to 9 months (<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>) with a total of 148 participants and two studies looked at 12 to 18 months (<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK>) involving 112 participants. At 6 to 9 months HbA1c was reduced by a significantly greater amount from baseline with group education versus individual education with a WMD of 0.8% (95% CI 0.3 to 1.3, P = 0.0007), however there was no significant difference between the interventions at 12 to 18 months with a WMD of 0.03% (95% CI -0.02 to 0.1, P = 0.22). There was no heterogeneity between these studies (I<SUP>2</SUP> = 0%).</P>
<P>Using the correlation coefficient of r = 0.25 did not substantially change the outcome with the WMD at 6 to 9 months of 0.8% (95% CI 0.2 to 1.5).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Body mass index (BMI)</HEADING>
<P>Only some studies looked at body mass index (BMI).</P>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus usual care</HEADING>
<P>There was only one study which looked at BMI at 6 to 9 months and this study only involved women (<LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>). Therefore, the analysis focused on 12 months where two studies were available (<LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>; <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>) involving 312 participants. There was no significant decrease in BMI at 12 to 18 months with a WMD of -0.2 BMI units (95% CI -1.0 to 0.6, P = 0.62).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus group education</HEADING>
<P>
<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK> and <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK> contained data on BMI available at 6 to 9 months involving 169 participants and <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK> and <LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK> had data at 12 to 18 months involving 123 participants. There was no significant heterogeneity at 6 to 9 months (I<SUP>2</SUP> = 0%) or at 12 to 18 months (I<SUP>2</SUP> = 22.9%). There was no significant difference between individual and group education in reduction in BMI at 6 to 9 months (WMD of -0.1 BMI units (95% CI of -0.9 to 0.7, P = 0.77) or at 12 to 18 months (-0.01 BMI units with a 95% CI of -0.8 to 0.7, P = 0.98).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Blood Pressure</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus usual care</HEADING>
<P>Data were available for systolic and diastolic blood pressure at 12 to 18 months for three studies (<LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>; <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>) with 625 and 624 participants, respectively.</P>
<P>Individual education had no significant effect on systolic blood pressure with a WMD of -2 mm Hg (95% CI -5 to 1, P = 0.19). There was no significant heterogeneity between the studies (I<SUP>2</SUP> = 3.0%).</P>
<P>There was a trend favouring individual education for reduction in diastolic blood pressure with a WMD of -2 mm Hg (95% CI -3 to 0.00, P = 0.05). There was moderate heterogeneity (I<SUP>2</SUP>= 48.4%) between the studies.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus group education</HEADING>
<P>Two studies measured systolic and diastolic blood pressure at 12 to 18 months (<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK>). There was no heterogeneity between the studies (I<SUP>2</SUP> = 0%) and no significant difference between individual and group education on reduction in systolic (WMD 4 mm Hg; 95% CI -4 to 12, P = 0.33) or diastolic blood pressure (WMD 2 mm Hg; 95% CI -4 to 7, P = 0.59).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Cholesterol</HEADING>
<P>Again, only a few studies assessed cholesterol and often measured different subsets such as HDL-cholesterol or triglycerides. Only total cholesterol had an adequate number of studies at 12 to 18 months and only in the individual education versus usual care analysis.</P>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus usual care</HEADING>
<P>Three studies assessed total cholesterol at 12 to 18 months (<LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>; <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>) and involved 627 participants. There was low heterogeneity between the studies (I<SUP>2</SUP> = 25.2%). Individual patient education had no significant effect on total cholesterol compared with usual care with a WMD of -0.03 mmol/L (95% CI -0.2 to 0.10, P = 0.66).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus group education</HEADING>
<P>Only one study (<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>) assessed total cholesterol which demonstrated no significant difference between individual education and group education in change in total cholesterol over 3, 6 or 12 months.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Smoking</HEADING>
<P>Only two studies reported smoking rates; one comparing individual to usual care (<LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK>) and the other comparing individual to group education (<LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK>). The study by <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK> had only a small number of smokers in each group and the percentages of smokers were significantly different between the two groups at baseline. There was a significant reduction in the number of participants who quit or reduced the amount of smoking in those receiving individual education versus usual care (16.7% versus 5.7%, P = 0.031). In the <LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK> study, group education just failed to reach significance in favouring smoking cessation over individual education ( P = 0.05). Again, there were substantial differences in the number of smokers between the groups at baseline (12% in the group with individual education versus 31% of those receiving group education).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Diabetes Knowledge</HEADING>
<P>Only three studies looked at knowledge (<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK> and <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>) and because they all used different questionnaires to assess knowledge, involved different intervention groups and were of different duration, a meta-analysis was not performed.</P>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus usual care</HEADING>
<P>
<LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK> found individual education significantly improved all knowledge subsets at six months. For example at six months, 78% of the study group could name one complication of diabetes compared with 18% at the start of the study and there was no significant change in the control group. There was no longer term follow-up.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus group education</HEADING>
<P>
<LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK> used a 14 point knowledge score to assess knowledge at baseline and six months. Both the group and individual intervention groups had significant improvements in knowledge compared to baseline, however there was no significant difference between individual and group education in knowledge scores (P = 0.15). <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK> used a 15 item diabetes knowledge scale. There was a significant difference between the groups at 6 months (P = 0.000) favouring group education but no significance between group and individual education at 12 months.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Quality of life and psychosocial adjustment</HEADING>
<P>SF-36 is a global health-related quality of life instrument measuring quality of life both in both physical and mental components. <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK> used a Japanese version of SF-36 and a Problem Areas in Diabetes Scale (PAID) to assess quality of life and diabetes-related distress. <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK> used the standard PAID survey to assess diabetes-related distress and the Diabetes Questionnaire (TDQ) to assess how well diabetes was integrated into daily life. <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK> included an adjustment to diabetes instrument (ATT19) which measures psychosocial adjustment and attitudes towards diabetes in addition to the SF-36 scale.</P>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus usual care</HEADING>
<P>In the <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK> study, women who participated in the individual intervention demonstrated significantly better psychosocial adaptation at six months with less distress (P &lt; 0.01) and better integration (P &lt; 0.03) than women under usual care. In the <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK> study there was no significant change in distress scores (PAID scores) or quality of life scores as measured by the Japanese version of SF-36 over a 12 month period.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Individual education versus group education</HEADING>
<P>In the <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK> study there were significant improvements in adjustment as measured by the ATT-19 survey and quality of life on the SF-36 mental scale in both individual and group interventions after six months. There was no significant difference between individual and group education.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Self management outcomes</HEADING>
<P>Only two studies looked at some aspect of self management. In the <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK> study, women who participated in the individual intervention demonstrated significantly better diet self-management (P = 0.02) with a trend towards better exercise self-management (P = 0.13). <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK> assessed self-reported exercise frequency and duration and behavioural goal achievement. There was no significant difference in percent of behavioural goals achieved between the group and individual education groups (P = 0.49) and no affect on self reported physical activity after six months within each group (intervention, P = 0.38; control group P = 0.39) or between the two groups (P = 0.83).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Cost effectiveness</HEADING>
<P>No study carried out a cost effectiveness analysis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis</HEADING>
<P>There were inadequate data to perform a subgroup analysis on ethnic background or gender.</P>
<SUBSECTION>
<HEADING LEVEL="4">Level of baseline HbA1c</HEADING>
<P>An analysis of individual versus usual care in studies where the mean HbA1c at baseline was greater than 8% (<LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK>; <LINK REF="STD-Ko--2004" TYPE="STUDY">Ko 2004</LINK> and <LINK REF="STD-Hawthorne-1997" TYPE="STUDY">Hawthorne 1997</LINK>), demonstrated that individual education was significantly better at improving HbA1c than usual care with a weighted mean difference of -0.3% (95% CI -0.5 to -0.1, P = 0.007).</P>
</SUBSECTION>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-11-24 10:22:12 +0100" MODIFIED_BY="Bernd Richter">
<P>There were only nine studies that met the fairly strict inclusion criteria and only four that compared individual education to usual care. Many studies were excluded from the review because the intervention involved a combination of group and individual education, the education was not face-to-face or it focused on a specific area. The included studies were generally of poor quality with the majority having a high risk of bias. The main shortcomings were the small numbers, high drop out rates, inadequate allocation concealment and lack of intention-to-treat analysis.</P>
<SUBSECTION>
<HEADING LEVEL="2">Individual education versus usual care</HEADING>
<P>Interestingly, individual education when compared to usual care did not have a significant impact on glycaemic control as reflected by glycated haemoglobin A1c (HbA1c) at 6 to 9 months or 12 to 18 months. There are perhaps a number of factors which contributed to this which should be assessed in future studies. Firstly, the face-to-face time was fairly limited in most studies with an average of 2 to 4 hours over a six month period. The longest in this group being <LINK REF="STD-Hiss-2001" TYPE="STUDY">Hiss 2001</LINK> with an average of four hours face-to-face time. Secondly, the majority of the intervention was within the first three months (except <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>) and in a number of studies there was indeed some evidence of benefit earlier on which however faded over time (<LINK REF="STD-Goudswaard-2004" TYPE="STUDY">Goudswaard 2004</LINK>; <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK>). In the meta-analysis, there was a trend to favour individual patient education at 6 to 9 months, with a weighted mean difference of -0.2%, however this did not reach significance (95% CI -0.5 to 0.03, P = 0.08). Further studies need to assess whether an intervention over a longer period of time would be more effective. Thirdly, the impact may have been diluted because in some studies there did not appear to be a great difference in the intervention between the individual education and usual care groups. For example, in the study by <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK>, both groups received monthly reviews by a diabetologist which may explain why the intervention of 25 minutes monthly did not have a substantial impact. Fourthly, the impact may have been diluted by including a high number of participants who had a near normal HbA1c at baseline. In a subgroup analysis focused on studies where participants had an average baseline HbA1c of greater than 8% there was a significant impact of individual education on glycaemic control (P =0.007).</P>
<P>There did not appear to be a significant impact of individual education on body mass index, blood pressure or total cholesterol. However, again there were small numbers and the above considerations should also be applied. Although there were very limited data available, there was a suggestion of benefit of individual education on dietary self management, diabetes knowledge and smoking habits. There was conflicting evidence surrounding psychosocial outcomes with <LINK REF="STD-Whittemore-2004" TYPE="STUDY">Whittemore 2004</LINK> demonstrating a significant improvement in quality of life and adaptation scores at six months in women, in contrast to the study by <LINK REF="STD-Shibayama-2007" TYPE="STUDY">Shibayama 2007</LINK> which showed no evidence of impact on quality of life scores.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="2">Individual versus group education</HEADING>
<P>There were only three studies which compared individual education to group education. Studies which focused on group education were excluded when the control group did not have a structured approach to individual education. Overall the quality of the studies was poor with small numbers and high drop-out rates (<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>; <LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>). In addition, there was a significant difference in the amount of patient contact time. For example, in <LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>, those receiving group education at 12 months had received an average of 21 hours contact time compared to participants who received individual education who received an average of only seven hours contact time. This must be taken into consideration when making conclusions from these studies.</P>
<P>Group education appeared to have a greater impact on glycaemic control than individual education at 6 to 9 months with a weighted mean difference of HbA1c of 0.8% (95% CI 0.3 to 1.3, P = 0.0007), however there was no significant difference between the interventions at 12 to 18 months with a weighted mean difference of 0.03% (95% CI -0.02 to 0.1, P = 0.22).</P>
<P>There was no significant difference between the impact of individual education and group education on body mass index, systolic or diastolic blood pressure with both groups having an improvement from baseline during the study.</P>
<P>There was a suggestion in the <LINK REF="STD-Dalmau-2003" TYPE="STUDY">Dalmau 2003</LINK> study that group education may be favoured over individual education for smoking cessation, however this just failed to reach significance ( P = 0.05), and only one study examined this outcome. Diabetes knowledge improved significantly in both group and individual education intervention groups and there was no significant difference between them at six months (<LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>) or 12 months (<LINK REF="STD-Campbell-1996" TYPE="STUDY">Campbell 1996</LINK>).</P>
<P>There was no significant difference between the effects of individual and group education on quality of life measures as both appeared to have a benefit as measured by the ATT-19 survey and quality of life on the SF-36 mental scale (<LINK REF="STD-Rickheim-2002" TYPE="STUDY">Rickheim 2002</LINK>). In the same study there was no significant affect on self reported physical activity after six months within each group.</P>
<P>These findings reflect the difficulties of educational research - including the lack of clear definition and documentation of the precise nature, extent and scope of interventions, and the lack of agreed predetermined goal and outcomes of education.</P>
</SUBSECTION>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2008-11-21 12:17:03 +0100" MODIFIED_BY="Bernd Richter">
<IMPLICATIONS_PRACTICE MODIFIED="2008-11-21 12:17:03 +0100" MODIFIED_BY="Bernd Richter">
<P>This systematic review highlights the benefits of individual education in lowering glycated haemoglobin A1c (HbA1c) in a subgroup of patients with poorer control and a mean baseline HbA1c greater than 8%. There did not appear to be a significant impact of individual education on body mass indexI, blood pressure or total cholesterol, at 12 to 18 months follow-up. However, in view of the small number of studies and their considerable limitations, further research is needed before any firm conclusions can be made.</P>
<P>There were even smaller number of studies (three) comparing individual face-to-face education to group education. Both individual and group education had an equal impact on HbA1c improvement at 12 to 18 months. There were only two studies that looked at other physical measures such as body mass index and blood pressure at 12 to 18 months. There was no significant difference between the impact of individual education and group education on body mass index, systolic or diastolic blood pressure with both groups having an improvement from baseline during the study.</P>
<P>There is no clear evidence in the current literature to assist in recommending either individual or group education over the other. Further high quality research on the effectiveness of different methods and delivery modes of education is urgently needed to guide resource allocation and service configuration for diabetes education programmes.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2008-10-31 16:47:19 +0100" MODIFIED_BY="Bernd Richter">
<P>As outlined in the discussion, there were considerable limitations in the number and quality of the studies available for this review. Critical assessment of the impact of individual diabetes patient education requires further research based on rigorous methods in high quality studies - including well designed RCTs comparing individual diabetes patient education with group education. Studies with larger numbers, longer duration and well defined, clearly documented interventions are vital to answering the question posed by this review. In particular, more explicitly defined differences between study and control groups in relation to time and duration of face-to-face education would reduce the dilutional effects of the intervention.</P>
<P>The participants in the majority of studies on diabetes patient education are recruited from among patients attending hospital based specialist diabetes centres or clinics where multidisciplinary or team care following internationally recommended standards of diabetes care is practised. It is reasonable to assume that this patient population is likely to be in better metabolic control than their counterparts in the community who do not attend such services. The significant benefit of individual education on glycaemic control in a subgroup analysis of three studies involving participants with a higher mean baseline HbA1c greater than 8% may suggest that one of the difficulties in demonstrating benefits of education on clinical parameters of diabetes control relates to the fact that patients recruited to studies of diabetes education are already in reasonable metabolic control. This potential effect requires further exploration.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-11-21 12:28:18 +0100" MODIFIED_BY="Bernd Richter">
<P>Cochrane Renal Group Westmead for advice and support.<BR/>Massimo Porta, MD, PhD, Marina Trento B. ED. SCI. for further clarification of their research groups.<BR/>Susan Goodall for assistance with study design and protocol development.<BR/>The contribution of Dr Siva S. Sivarajasingam is also acknowledged.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-11-12 15:38:00 +0100" MODIFIED_BY="Bernd Richter">
<P>SALLY-ANNE DUKE: developed the search strategy; co-selected studies and undertook selection, quality assessment, data extraction, data analysis, and was the primary writer of the final review.</P>
<P>STEPHEN COLAGIURI: advised on design, methods and data analysis, assisted with study selection and reviewed all selected articles</P>
<P>RUTH COLAGIURI: was primarily responible for the protocol, design, co-selection of all studies and contributed to the writing of the final review.</P>
<P>All three authors were invovled in developing study selection critieria and received and commented on successive drafts of the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES MODIFIED="2008-10-31 12:23:24 +0100" MODIFIED_BY="Bernd Richter">
<P>Conversion from US$ to EUROS was based on 31st Oktober 2008 rates. </P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-21 12:09:12 +0100" MODIFIED_BY="Bernd Richter">
<STUDIES MODIFIED="2008-11-21 12:09:12 +0100" MODIFIED_BY="Bernd Richter">
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Campbell-1996" NAME="Campbell 1996" YEAR="1996">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Campbell E M, Redman S, Moffitt PS, Sanson-Fisher RW</AU>
<TI>The relative effectiveness of educational and behavioral instruction programs for patients with NIDDM: a randomized trial</TI>
<SO>Diabetes Educator</SO>
<YR>1996</YR>
<VL>22</VL>
<NO>4</NO>
<PG>379-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dalmau-2003" NAME="Dalmau 2003" YEAR="2003">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dalmau Llorca MR, Garcia Bernal G, Aguilar Martin C, Palau Galindo A</AU>
<TI>[Group versus individual education for type-2 diabetes patients]</TI>
<SO>Atencion Primaria</SO>
<YR>2003</YR>
<VL>32</VL>
<NO>1</NO>
<PG>36-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Goudswaard-2004" NAME="Goudswaard 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Goudswaard AN, Stolk RP, Zuithoff NP, de Valk HW, Rutten GE</AU>
<TI>Long-term effects of self-management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care</TI>
<SO>Diabetic Medicine</SO>
<YR>2004</YR>
<VL>21</VL>
<NO>5</NO>
<PG>491-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hawthorne-1997" NAME="Hawthorne 1997" YEAR="1997">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hawthorne K, Tomlinson S</AU>
<TI>One-to-one teaching with pictures- flashcard health education for Bristish Asians with diabetes</TI>
<SO>British Journal of General Practice</SO>
<YR>1997</YR>
<VL>47</VL>
<PG>301-304</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hiss-2001" NAME="Hiss 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hiss RG, Lou Gillard M, Armbruster BA, McClure LA</AU>
<TI>Comprehensive evaluation of community-based diabetic patients: Effect of feedback to patients and their physicians: A randomized controlled trial</TI>
<SO>Diabetes Care</SO>
<YR>2001</YR>
<VL>24</VL>
<NO>4</NO>
<PG>690-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ko--2004" NAME="Ko  2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ko GTC, Li JKY, Kan ECY, Lo MKW</AU>
<TI>Effects of a structured health education programme by a diabetic education nurse on cardiovascular risk factors in Chinese Type 2 diabetic patients: a 1-year prospective randomized study</TI>
<SO>Diabetic Medicine</SO>
<YR>2004</YR>
<VL>21</VL>
<PG>1274-1279</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rickheim-2002" NAME="Rickheim 2002" YEAR="2002">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rickheim PL, Weaver TW, Flader JL, Kendall DM</AU>
<TI>Assessment of group versus individual diabetes education: a randomized study</TI>
<SO>Diabetes Care</SO>
<YR>2002</YR>
<VL>25</VL>
<NO>2</NO>
<PG>269-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shibayama-2007" NAME="Shibayama 2007" YEAR="2007">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shibayama T, Kobayashi K, Takano A, Kadowaki T, Kazuma K</AU>
<TI>Effectiveness of lifestyle counseling by certified expert nurse of Japan for non-insulin-treated diabetic outpatients: A 1-year randomized controlled trial</TI>
<SO>Diabetes Research and Clinical Practice</SO>
<YR>2007</YR>
<VL>76</VL>
<PG>265-268</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Whittemore-2004" NAME="Whittemore 2004" YEAR="2004">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Whittemore R, Melkus GD, Sullivan A, Grey M</AU>
<TI>A nurse-coaching intervention for women with type 2 diabetes</TI>
<SO>Diabetes Educator</SO>
<YR>2004</YR>
<VL>30</VL>
<NO>5</NO>
<PG>795-804</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2008-11-21 12:09:12 +0100" MODIFIED_BY="Bernd Richter">
<STUDY DATA_SOURCE="PUB" ID="STD-Aas--2005" NAME="Aas  2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aas, A M., I. Bergstad, et al</AU>
<TI>An intensified lifestyle intervention programme may be superior to insulin treatment in poorly controlled Type 2 diabetic patients on oral hypoglycaemic agents: results of a feasibility study</TI>
<SO>Diabetic Medicine</SO>
<YR>2005</YR>
<VL>22</VL>
<NO>3</NO>
<PG>316-322</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Anderson---2005" NAME="Anderson   2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Anderson, R M., M. M. Funnell, et al.</AU>
<TI>Evaluating a problem-based empowerment program for African Americans with diabetes: results of a randomized controlled trial</TI>
<SO>Ethnicity and Disease</SO>
<YR>2005</YR>
<VL>15</VL>
<NO>4</NO>
<PG>671-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bacardi_x002d_Gascon--2004" NAME="Bacardi-Gascon  2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bacardi-Gascon, M , P. Rosales-Garay, et al.</AU>
<TI>Effect of Diabetes Intervention Programs on Physical Activity among Migrant Mexican Women with Type 2 Diabetes</TI>
<SO>Diabetes Care</SO>
<YR>2004</YR>
<VL>27</VL>
<NO>2</NO>
<PG>616</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baradaran--2006" NAME="Baradaran  2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baradaran, H R., R. P. Knill-Jones, et al.</AU>
<TI>A controlled trial of the effectiveness of a diabetes education programme in a multi-ethnic community in Glasgow [ISRCTN28317455]</TI>
<SO>BMC Public Health</SO>
<YR>2006</YR>
<VL>6</VL>
<PG>134</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Baran--1999" NAME="Baran  1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Baran, R W., K. Crumlish, et al.</AU>
<TI>Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling</TI>
<SO>American Journal of Health-System Pharmacy</SO>
<YR>1999</YR>
<VL>56</VL>
<NO>15</NO>
<PG>1535-1539</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barcelo--2001" NAME="Barcelo  2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barcelo, A , S. Robles, et al.</AU>
<TI>An intervention to improve diabetes control in Chile. [Spanish]</TI>
<SO>Revista Panamericana de Salud Publica/Pan American Journal of Public Health.</SO>
<YR>2001</YR>
<VL>10</VL>
<NO>5</NO>
<PG>328-333</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Barth--1991" NAME="Barth  1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Barth, R , L. V. Campbell, et al.</AU>
<TI>Intensive education improves knowledge, compliance, and foot problems in type 2 diabetes,</TI>
<SO>Diabetic Medicine.</SO>
<YR>1991</YR>
<VL>8</VL>
<NO>2</NO>
<PG>111-117</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bloomgarden-1987" NAME="Bloomgarden 1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bloomgarden, Z T., W. Karmally, et al.</AU>
<TI>Randomized, controlled trial of diabetic patient education: Improved knowledge without improved metabolic status,</TI>
<SO>Diabetes Care</SO>
<YR>1987</YR>
<VL>10</VL>
<NO>3</NO>
<PG>263-272</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bradshaw--2006" NAME="Bradshaw  2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Bradshaw, B G</AU>
<TI>The efficacy of a resiliency training program in adults with type 2 diabetes mellitus</TI>
<SO>Thesis Univeristy of Utah</SO>
<YR>2006</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Browning--2003" NAME="Browning  2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Browning, C J. and S. A. Thomas</AU>
<TI>Six-month outcome data for the Good Life Club project: an outcomes study of diabetes self-management.</TI>
<SO>Special Issue: The Management of Chronic Disease in Primary Care Settings</SO>
<YR>2003</YR>
<VL>9</VL>
<PG>192-198</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cabrera_x002d_Pivaral-2000" NAME="Cabrera-Pivaral 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cabrera-Pivaral, C E., G. Gonzalez-Perez, et al.</AU>
<TI>Effects of behavior-modifying education in the metabolic profile of the type 2 diabetes mellitus patient</TI>
<SO>Journal of Diabetes &amp; its Complications</SO>
<YR>2000</YR>
<VL>14</VL>
<NO>6</NO>
<PG>322-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chen--2003" NAME="Chen  2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chen, Y S., W. C. Xu, et al.</AU>
<TI>Significance of reinforcing management on limb salvage therapy in patients at high risk for diabetic foot. [Chinese],</TI>
<SO>Zhongguo Linchuang Kangfu</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>18</NO>
<PG>2556-2557</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cleghorn---2004" NAME="Cleghorn   2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cleghorn, G D., M. Nguyen, et al.</AU>
<TI>Practice-based interventions to improve health care for Latinos with diabetes</TI>
<SO>Ethnicity &amp; Disease</SO>
<YR>Summer 2004</YR>
<VL>1</VL>
<PG>117-121</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Clifford--2005" NAME="Clifford  2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Clifford, R M., W. A. Davis, et al.</AU>
<TI>Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study</TI>
<SO>Diabetes Care</SO>
<YR>2005</YR>
<VL>28</VL>
<NO>4</NO>
<PG>771-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cooper--2003" NAME="Cooper  2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Cooper, H , K. Booth, et al.</AU>
<TI>Using combined research methods for exploring diabetes patient education</TI>
<SO>Patient Education &amp; Counseling</SO>
<YR>2003</YR>
<VL>51</VL>
<NO>1</NO>
<PG>45-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-D_x0027_Eramo_x002d_Melkus-1992" NAME="D'Eramo-Melkus 1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>D'Eramo-Melkus, G A., J. Wylie-Rosett, et al.</AU>
<TI>Metabolic impact of education in NIDDM</TI>
<SO>Diabetes Care</SO>
<YR>1992</YR>
<VL>15</VL>
<NO>7</NO>
<PG>864-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Weerdt_x002c_-I._x002c_-1991" NAME="De Weerdt, I., 1991" YEAR="1989">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>De Weerdt, I , A. P. Visser, et al.</AU>
<TI>Randomized controlled multicentre evaluation of an education programme for insulin-treated diabetic patients: Effects on metabolic control, quality of life, and costs of therapy,</TI>
<SO>Diabetic Medicine.</SO>
<YR>1991</YR>
<VL>8</VL>
<NO>4</NO>
<PG>338-345</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deakin--2006" NAME="Deakin  2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deakin, T A., J. E. Cade, et al.</AU>
<TI>Structured patient education: the Diabetes X-PERT Programme makes a difference</TI>
<SO>Diabetic Medicine</SO>
<YR>2006</YR>
<VL>23</VL>
<NO>9</NO>
<PG>944-954</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Di--Loreto--2003" NAME="Di  Loreto  2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Di Loreto, C , C. Fanelli, et al.</AU>
<TI>Validation of a counseling strategy to promote the adoption and the maintenance of physical activity by type 2 diabetic subjects</TI>
<SO>Diabetes Care</SO>
<YR>2003</YR>
<VL>26</VL>
<NO>2</NO>
<PG>404-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dijkstra--2006" NAME="Dijkstra  2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dijkstra, R F., L. W. Niessen, et al</AU>
<TI>Patient-centred and professional-directed implementation strategies for diabetes guidelines: A cluster-randomized trial-based cost-effectiveness analysis,</TI>
<SO>Diabetic Medicine</SO>
<YR>2006</YR>
<VL>23</VL>
<NO>2</NO>
<PG>164-170</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dongbo-2003" NAME="Dongbo 2003" YEAR="2003">
<REFERENCE NOTES="&lt;p&gt;Dongbo, F., F. Hua, et al. (2003). Implementation and quantitative evaluation of chronic disease self-management programme in Shanghai, China: Randomized controlled trial, Bulletin of the World Health Organization. Vol. 81(3)(pp 174-182), 2003.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dongbo, F , F. Hua, et al</AU>
<TI>Implementation and quantitative evaluation of chronic disease self-management programme in Shanghai, China: Randomized controlled trial,</TI>
<SO>Bulletin of the World Health Organization</SO>
<YR>2003</YR>
<VL>81</VL>
<NO>3</NO>
<PG>174-182</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Donohoe--2000" NAME="Donohoe  2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;Donohoe, M. E., J. A. Fletton, et al. (2000). Improving foot care for people with diabetes mellitus - A randomized controlled trial of an integrated care approach, Diabetic Medicine. Vol. 17(8)(pp 581-587), 2000.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Donohoe, E., J. A. Fletton, et al.</AU>
<TI>Improving foot care for people with diabetes mellitus - A randomized controlled trial of an integrated care approach,</TI>
<SO>Diabetic Medicine</SO>
<YR>2000</YR>
<VL>17</VL>
<NO>8</NO>
<PG>581-587</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fan--1999" NAME="Fan  1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fan, L, J. Zhu, et al.</AU>
<TI>Effect of diabetic education on patients' knowledge and self-management ability [Chinese]</TI>
<SO>Hong Kong Nursing Journal</SO>
<YR>1999</YR>
<VL>35</VL>
<NO>2</NO>
<PG>15-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fan_x002c_-M.-J._x002c_-G.-2002" NAME="Fan, M. J., G. 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fan, M J., G. H. Wu, et al.</AU>
<TI>Effect evaluation of health education in 80 cases of type 2 diabetes,</TI>
<SO>Zhongguo Linchuang Kangfu</SO>
<YR>2002</YR>
<VL>6</VL>
<NO>21</NO>
<PG>3298</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fornos--2006" NAME="Fornos  2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fornos, J A., N. F. Andres, et al.</AU>
<TI>A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain</TI>
<SO>Pharmacy World &amp; Science</SO>
<YR>2006</YR>
<VL>28</VL>
<NO>2</NO>
<PG>65-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fu--2003" NAME="Fu  2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fu, D , H. Fu, et al.</AU>
<TI>Implementation and quantitative evaluation of chronic disease self-management programme in Shanghai, China: Randomized controlled trial</TI>
<SO>Bulletin of the World Health Organization</SO>
<YR>2003</YR>
<VL>81</VL>
<NO>3</NO>
<PG>174-182</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fukuda-1999" NAME="Fukuda 1999" YEAR="">
<REFERENCE NOTES="&lt;p&gt;Fukuda H, M. T. K. R. Evaluation of a diabetes patient education program consisting of a three-day hospitalization and a six-month follow-up by telephone counseling for mild type 2 diabetes and IGT, Environmental Health &amp;amp; Preventive Medicine. 4(3):122-129, 1999.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fukuda H, M</AU>
<TI>Evaluation of a diabetes patient education program consisting of a three-day hospitalization and a six-month follow-up by telephone counseling for mild type 2 diabetes and IGT</TI>
<SO>Environmental Health &amp; Preventive Medicine</SO>
<YR>1999</YR>
<VL>4</VL>
<NO>3</NO>
<PG>122-129</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gabbay---2006" NAME="Gabbay   2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gabbay, R A., I. Lendel, et al.</AU>
<TI>Nurse case management improves blood pressure, emotional distress and diabetes complication screening,</TI>
<SO>Diabetes Research &amp; Clinical Practice</SO>
<YR>2006</YR>
<VL>71</VL>
<NO>1</NO>
<PG>28-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gaede--2001" NAME="Gaede  2001" YEAR="2001">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gaede, P , M. Beck, et al</AU>
<TI>Limited impact of lifestyle education in patients with Type 2 diabetes mellitus and microalbuminuria: results from a randomized intervention study</TI>
<SO>Diabetic Medicine</SO>
<YR>2001</YR>
<VL>18</VL>
<NO>2</NO>
<PG>104-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gallegos-2006" NAME="Gallegos 2006" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gallegos, E C., F. Ovalle-Berumen, et al.</AU>
<TI>Metabolic control of adults with type 2 diabetes mellitus through education and counseling</TI>
<SO>Journal of Nursing Scholarship</SO>
<YR>2006</YR>
<VL>38</VL>
<NO>4</NO>
<PG>344-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gary--2003" NAME="Gary  2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gary, T L., L. R. Bone, et al</AU>
<TI>Randomized controlled trial of the effects of nurse case manager and community health worker interventions on risk factors for diabetes-related complications in urban African Americans</TI>
<SO>Preventive Medicine</SO>
<YR>2003</YR>
<VL>37</VL>
<NO>1</NO>
<PG>23-32</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gentile--2004" NAME="Gentile  2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gentile, L , E. Borgo, et al.</AU>
<TI>ROMEO: Rethink Organization to improve education and outcomes. A randomised controlled multicentre trial of group care for the management of type 2 diabetes. [Italian],</TI>
<SO>Giornale Italiano di Diabetologia e Metabolismo.</SO>
<YR>2004</YR>
<VL>24</VL>
<NO>1</NO>
<PG>9-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ghosh--2007" NAME="Ghosh  2007" YEAR="2007">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ghosh, H A., A. Shaar, et al.</AU>
<TI>Diabetes control in 3 villages in Palestine: A community-based quality improvement intervention,</TI>
<SO>Journal of Ambulatory Care Management.</SO>
<YR>2007</YR>
<VL>30</VL>
<NO>1</NO>
<PG>74-78</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gilliland--2002" NAME="Gilliland  2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gilliland, S S., S. P. Azen, et al.</AU>
<TI>Strong in body and spirit: Lifestyle intervention for Native American adults with diabetes in New Mexico,</TI>
<SO>Diabetes Care</SO>
<YR>2002</YR>
<VL>25</VL>
<NO>1</NO>
<PG>78-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glasgow" NAME="Glasgow" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glasgow Re, T</AU>
<TI>Nutrition education and social learning interventions for type II diabetes.</TI>
<SO>Diabetes care</SO>
<YR>1989</YR>
<VL>12</VL>
<NO>2</NO>
<PG>150-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hae---2005" NAME="Hae   2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hae, M C., S. Mitrovich, et al</AU>
<TI>Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: A randomized controlled trial</TI>
<SO>American Journal of Managed Care</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>4</NO>
<PG>253-260</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hajdinjak--2003" NAME="Hajdinjak  2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hajdinjak, D and M. Cokolic</AU>
<TI>Improvement of control of type 2 diabetes after patient education</TI>
<SO>Diabetes &amp; Metabolism</SO>
<YR>2003</YR>
<VL>29</VL>
<PG>(Hors serie 2)</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hanefeld--1991" NAME="Hanefeld  1991" YEAR="1991">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hanefeld, M , S. Fischer, et al</AU>
<TI>Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM</TI>
<SO>1991</SO>
<YR>Diabetes Care</YR>
<VL>14</VL>
<NO>4</NO>
<PG>308-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Holtrop--2002" NAME="Holtrop  2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Holtrop, J S., J. Hickner, et al.</AU>
<TI>"Sticking to it -- diabetes mellitus": a pilot study of an innovative behavior change program for women with type 2 diabetes</TI>
<SO>American Journal of Health Education</SO>
<YR>2002</YR>
<VL>33</VL>
<NO>3</NO>
<PG>161-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jayasuriya---2000" NAME="Jayasuriya   2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jayasuriya, R , R. Griffiths, et al.</AU>
<TI>Outcome assessment of a community based model of general practitioner care diabetes patients,</TI>
<SO>Practical Diabetes International</SO>
<YR>2000</YR>
<VL>17</VL>
<NO>6</NO>
<PG>179-182</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jones---2003" NAME="Jones   2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jones, H , L. Edwards, et al.</AU>
<TI>Changes in diabetes self-care behaviors make a difference in glycemic control - The diabetes stages of change (DiSC) study</TI>
<SO>Diabetes care</SO>
<YR>2003</YR>
<VL>26</VL>
<NO>3</NO>
<PG>732-737</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jungmann---1997" NAME="Jungmann   1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jungmann, E , G. Jungmann, et al.</AU>
<TI>Patient education of non-insulin-dependent diabetic patients. Effect of an ambulatory educational program on metabolism and risk factors</TI>
<SO>Fortschritte der Medizin</SO>
<YR>1997</YR>
<VL>115</VL>
<PG>20-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kirk--2004" NAME="Kirk  2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Kirk, A , N. Mutrie, et al.</AU>
<TI>Effects of a 12-month activity counselling intervention on glycaemic control and on the status of cardiovascular risk factors in people with Type 2 diabetes,</TI>
<SO>Diabetologia</SO>
<YR>2004</YR>
<VL>47</VL>
<NO>5</NO>
<PG>821-832</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ko_x002c_-S.-H._x002c_-K.--2007" NAME="Ko, S. H., K.  2007" YEAR="2007">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ko, S H., K. H. Song, et al.</AU>
<TI>Long-term effects of a structured intensive diabetes education programme (SIDEP) in patients with Type 2 diabetes mellitus - A 4-year follow-up study,</TI>
<SO>Diabetic Medicine</SO>
<YR>2007</YR>
<VL>24</VL>
<NO>1</NO>
<PG>55-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Korhonen--1987" NAME="Korhonen  1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Korhonen, T , M. Uusitupa, et al.</AU>
<TI>Efficacy of dietary instructions in newly diagnosed non-insulin-dependent diabetic patients. Comparison of two different patient education regimens</TI>
<SO>Acta Medica Scandinavica</SO>
<YR>1987</YR>
<VL>222</VL>
<NO>4</NO>
<PG>323-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kronsbein---1988" NAME="Kronsbein   1988" YEAR="1988">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kronsbein, P , V. Jorgens, et al.</AU>
<TI>Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes</TI>
<SO>Lancet</SO>
<YR>1988</YR>
<VL>2</VL>
<PG>1407-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kulzer---2007" NAME="Kulzer   2007" YEAR="2007">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kulzer, B, N. Hermanns, et al.</AU>
<TI>Effects of self-management training in Type 2 diabetes: a randomized, prospective trial</TI>
<SO>Diabetic Medicine</SO>
<YR>2007</YR>
<VL>24</VL>
<NO>4</NO>
<PG>415-423</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Laitinen-1993" NAME="Laitinen 1993" YEAR="">
<REFERENCE NOTES="&lt;p&gt;Laitinen Jh, A. I. E. S. E. S. W. R. L. H.-I. P. A. U. M. I. &amp;quot;Impact of intensified dietary therapy on energy and nutrient intakes and fatty acid composition of serum lipids in patients with recently diagnosed non-insulin-dependent diabetes mellitus.&amp;quot; Journal of the American Dietetic Association. 93(3):276-83, 1993 Mar.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Laitinen Jh, A</AU>
<TI>Impact of intensified dietary therapy on energy and nutrient intakes and fatty acid composition of serum lipids in patients with recently diagnosed non-insulin-dependent diabetes mellitus.</TI>
<SO>Journal of the American Dietetic Association</SO>
<YR>1993</YR>
<VL>93</VL>
<NO>3</NO>
<PG>276-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li---2003" NAME="Li   2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li, X</AU>
<TI>Experiences of carrying out health education in type 2 diabetes patients [Chinese]</TI>
<SO>Chinese Nursing Research</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>2B</NO>
<PG>195-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Li_x002c_-X._x002c_-Y.-Cao_x002c_-2003" NAME="Li, X., Y. Cao, 2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li, X , Y. Cao, et al.</AU>
<TI>Effects of education on blood sugar and complications of 2 type diabetes,</TI>
<SO>Zhongguo Linchuang Kangfu</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>3</NO>
<PG>509</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Litzelman-1993" NAME="Litzelman 1993" YEAR="">
<REFERENCE NOTES="&lt;p&gt;Litzelman Dk, S. C. W. L. C. D. H. L. M. W. M. A. B. D. E. F. E. S. V. F. &amp;quot;Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial.&amp;quot; Annals of internal medicine. 119(1):36-41, 1993 Jul.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Litzelman Dk, S</AU>
<TI>Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial</TI>
<SO>Annals of internal medicine</SO>
<YR>1993</YR>
<VL>119</VL>
<NO>1</NO>
<PG>36-41, 1993</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lorig---2003" NAME="Lorig   2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lorig, K R., P. L. Ritter, et al</AU>
<TI>Hispanic chronic disease self-management: a randomized community-based outcome trial</TI>
<SO>Nursing Research</SO>
<YR>2003</YR>
<VL>52</VL>
<NO>6</NO>
<PG>361-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lou---2006" NAME="Lou   2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lou, V W. Q. and Y. Q. Zhang</AU>
<TI>Evaluating the effectiveness of a Participatory Empowerment Group for Chinese type 2 diabetes patients</TI>
<SO>Research on Social Work Practice</SO>
<YR>2006</YR>
<VL>16</VL>
<NO>5</NO>
<PG>491-499</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lozano--1999" NAME="Lozano  1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lozano, M L., M. J. Armale, et al.</AU>
<TI>[The education of type-2 diabetics: why not in groups?].[see comment][erratum appears in Aten Primaria 1999 Jul-Aug;24(3):178]</TI>
<SO>Atencion Primaria</SO>
<YR>1999</YR>
<VL>24</VL>
<NO>3</NO>
<PG>485-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maislos---2004" NAME="Maislos   2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maislos, M and D. Weisman</AU>
<TI>Multidisciplinary approach to patients with poorly controlled type 2 diabetes mellitus: A prospective, randomized study,</TI>
<SO>Acta Diabetologica</SO>
<YR>2004</YR>
<VL>41</VL>
<NO>2</NO>
<PG>44-48</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Martinus----2006" NAME="Martinus    2006" YEAR="2006">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinus, R , R. Corban, et al</AU>
<TI>Effect of psychological intervention on exercise adherence in type 2 diabetic subjects</TI>
<SO>Annals of the New York Academy of Sciences</SO>
<YR>2006</YR>
<VL>1084</VL>
<PG>350-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mayer_x002d_Davis--2004" NAME="Mayer-Davis  2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mayer-Davis, E J., A. M. D'Antonio, et al.</AU>
<TI>Pounds off with empowerment (POWER): A clinical trial of weight management strategies for black and white adults with diabetes who live in medically underserved rural communities,</TI>
<SO>American Journal of Public Health</SO>
<YR>2004</YR>
<VL>94</VL>
<NO>10</NO>
<PG>1736-1742</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mazzuca---1986" NAME="Mazzuca   1986" YEAR="1986">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mazzuca, S A., N. H. Moorman, et al.</AU>
<TI>The Diabetes Education Study: A controlled trial of the effects of diabetes patient education,</TI>
<SO>Diabetes Care</SO>
<YR>1986</YR>
<VL>9</VL>
<NO>1</NO>
<PG>1-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mshelia----2007" NAME="Mshelia    2007" YEAR="2007">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mshelia, D S., O. M. Akinosun, et al</AU>
<TI>Effect of increased patient-physician contact time and health education in achieving diabetes mellitus management objectives in a resource-poor environment</TI>
<SO>Singapore Medical Journal</SO>
<YR>2007</YR>
<VL>48</VL>
<NO>1</NO>
<PG>74-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Neder----2003" NAME="Neder    2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Neder, S , P. Nadash, et al.</AU>
<TI>Individualized education can improve foot care for patients with diabetes</TI>
<SO>Home Healthcare Nurse</SO>
<YR>2003</YR>
<VL>21</VL>
<NO>12</NO>
<PG>837-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Odegard----2005" NAME="Odegard    2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Odegard, P S., A. Goo, et al.</AU>
<TI>Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention</TI>
<SO>Annals of Pharmacotherapy</SO>
<YR>2005</YR>
<VL>39</VL>
<NO>3</NO>
<PG>433-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pedersen----2003" NAME="Pedersen    2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pedersen, O and P. Gaede</AU>
<TI>Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: The Steno-2 study,</TI>
<SO>Metabolism: Clinical &amp; Experimental.</SO>
<YR>2003</YR>
<VL>52</VL>
<NO>8 Suppl 1</NO>
<PG>19-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pennings_x002d_Van----1992" NAME="Pennings-Van    1992" YEAR="1992">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pennings-Van der Eerden, L , T. Ripken, et al</AU>
<TI>Evaluation of the impact of a patient education programme for NIDDM patients on knowledge, self-care behaviour, metabolic control and lipid profiles</TI>
<SO>Gedrag &amp; Gezondheid: Tijdschrift voor Psychologie en Gezondheid</SO>
<YR>1992</YR>
<VL>19</VL>
<NO>5</NO>
<PG>246-260</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Philis_x002d_Tsimikas-2004" NAME="Philis-Tsimikas 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Philis-Tsimikas, A , C. Walker, et al.</AU>
<TI>Improvement in diabetes care of underinsured patients enrolled in Project Dulce: A community-based, culturally appropriate, nurse case management and peer education diabetes care model</TI>
<SO>Diabetes Care</SO>
<YR>2004</YR>
<VL>27</VL>
<NO>1</NO>
<PG>110-115</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pibernik_x002d_Okanovi2004" NAME="Pibernik-Okanovi2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pibernik-Okanovic, M , M. Prasek, et al.</AU>
<TI>Effects of an empowerment-based psychosocial intervention on quality of life and metabolic control in type 2 diabetic patients</TI>
<SO>Patient Education and Counseling</SO>
<YR>2004</YR>
<VL>52</VL>
<NO>2</NO>
<PG>193-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trento-2001" MODIFIED="2008-11-21 12:09:12 +0100" MODIFIED_BY="Bernd Richter" NAME="Trento 2001" YEAR="2001">
<REFERENCE MODIFIED="2008-11-21 12:09:12 +0100" MODIFIED_BY="Bernd Richter" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trento M, Passera P et al</AU>
<TI>Group visits improve metabolic control in type 2 diabetes: a 2-year follow-up</TI>
<SO>Diabetes Care</SO>
<YR>2001</YR>
<VL>24</VL>
<NO>6</NO>
<PG>995-1000</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wilson---1987" NAME="Wilson   1987" YEAR="1987">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wilson, W , C. Pratt, et al.</AU>
<TI>The impact of diabetes education and peer support upon weight and glycemic control of elderly persons with noninsulin dependent diabetes mellitus (NIDDM)</TI>
<SO>American Journal of Public Health</SO>
<YR>1987</YR>
<VL>77</VL>
<NO>5</NO>
<PG>634-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wolf-----2004" NAME="Wolf     2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wolf, A M., M. R. Conaway, et al.</AU>
<TI>Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study.[see comment]</TI>
<SO>Diabetes Care</SO>
<YR>2004</YR>
<VL>27</VL>
<NO>7</NO>
<PG>1570-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Woollard--2003" NAME="Woollard  2003" YEAR="2003">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Woollard, J , V. Burke, et al.</AU>
<TI>Effects of general practice-based nurse-counselling on ambulatory blood pressure and antihypertensive drug prescription in patients at increased risk of cardiovascular disease</TI>
<SO>Journal of Human Hypertension</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>10</NO>
<PG>689-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-12 17:47:53 +0100" MODIFIED_BY="Bernd Richter">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-12 17:47:53 +0100" MODIFIED_BY="Bernd Richter">
<REFERENCE ID="REF-AADE-2003" NAME="AADE 2003" TYPE="JOURNAL_ARTICLE">
<AU>AADE</AU>
<TI>Standards for Outcomes Measurement of Diabetes Self-Management Education. Position Statement.</TI>
<SO>Diabetes Educator</SO>
<YR>2003</YR>
<VL>29</VL>
<NO>5</NO>
<PG>804-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ADA-1999" MODIFIED="2008-10-31 14:25:32 +0100" MODIFIED_BY="Bernd Richter" NAME="ADA 1999" TYPE="JOURNAL_ARTICLE">
<AU>The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus</AU>
<TI>Report of the Expert Committee on the diagnosis and classification of diabetes mellitus</TI>
<SO>Diabetes Care</SO>
<YR>1999</YR>
<VL>22 Suppl 1</VL>
<PG>S5-19</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-ADA-2003" NAME="ADA 2003" TYPE="JOURNAL_ARTICLE">
<AU>American Diabetes Association.</AU>
<TI>Economic costs of diabetes in the US in 2002.</TI>
<SO>Diabetes Care</SO>
<YR>2003</YR>
<VL>26</VL>
<PG>917-932</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Corabian-2001" MODIFIED="2008-08-07 04:57:24 +0200" MODIFIED_BY="[Empty name]" NAME="Corabian 2001" TYPE="OTHER">
<AU>Corabian P, Harstall C</AU>
<TI>Patient Diabetes Education in the Management of Adult Type 2 Diabetes</TI>
<SO>Health Technology Assessment - Alberta Heritage Foundation for Medical Research</SO>
<YR>2001</YR>
<VL>HTA 23 Series A</VL>
<NO>Feb</NO>
<PG>1-90</PG>
<PB>Alberta Heritage Foundation for Medical Research</PB>
<CY>Alberta</CY>
<IDENTIFIERS MODIFIED="2008-08-07 04:57:24 +0200" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Davies--2008" NAME="Davies  2008" TYPE="JOURNAL_ARTICLE">
<AU>Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S, et al.</AU>
<TI>Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.</TI>
<SO>BMJ</SO>
<YR>2008</YR>
<VL>336</VL>
<NO>7642</NO>
<PG>491-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deakin-2005" MODIFIED="2008-11-12 16:02:28 +0100" MODIFIED_BY="Bernd Richter" NAME="Deakin 2005" TYPE="COCHRANE_REVIEW">
<AU>Deakin T, McShane CE, Cade JE, Williams RDRR</AU>
<TI>Group based training for self-management strategies in people with thype 2 diabetes mellitus</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-11-12 16:02:28 +0100" MODIFIED_BY="Bernd Richter">
<IDENTIFIER MODIFIED="2008-11-12 16:02:28 +0100" MODIFIED_BY="Bernd Richter" TYPE="DOI" VALUE="10.1002/14651858.CD003417.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Deakin-2006" NAME="Deakin 2006" TYPE="JOURNAL_ARTICLE">
<AU>Deakin TA, Cade JE, Williams R, Greenwood DC</AU>
<TI>Structured patient education: the diabetes X-PERT Programme makes a difference</TI>
<SO>Diabetic Medicine</SO>
<YR>2006</YR>
<VL>23</VL>
<NO>9</NO>
<PG>944-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Diabetes-Atlas-2005" NAME="Diabetes Atlas 2005" TYPE="OTHER">
<AU>International Diabetes Federation.</AU>
<TI>Diabetes Atlas</TI>
<SO>www.idf.org/e-atlas.</SO>
<YR>2005</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Eigenmann-2007" MODIFIED="2008-11-12 17:47:53 +0100" MODIFIED_BY="Bernd Richter" NAME="Eigenmann 2007" TYPE="JOURNAL_ARTICLE">
<AU>Eigenmann C, Colagiuri R</AU>
<TI>Outcomes and Indicators for Diabetes Education - A National Consensus Position.</TI>
<SO>Diabetes Australia</SO>
<YR>2007</YR>
<VL>June</VL>
<PG>1-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ellis-2004" NAME="Ellis 2004" TYPE="JOURNAL_ARTICLE">
<AU>Ellis SE, Speroff T, Dittus RS, Brown A, Pichert JW, Elasy TA</AU>
<TI>Diabetes patient education: a meta-analysis and meta-regression</TI>
<SO>Patient Education &amp; Counseling</SO>
<YR>2004</YR>
<VL>52</VL>
<NO>1</NO>
<PG>97-105</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Funnell-2004" MODIFIED="2008-11-12 16:52:29 +0100" MODIFIED_BY="Bernd Richter" NAME="Funnell 2004" TYPE="JOURNAL_ARTICLE">
<AU>Funnell MM</AU>
<TI>Patient empowerment</TI>
<SO>Critical Care Nursing Quarterly</SO>
<YR>2004</YR>
<VL>27</VL>
<NO>2</NO>
<PG>201-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Glasgow-1999" NAME="Glasgow 1999" TYPE="JOURNAL_ARTICLE">
<AU>Glasgow R, Fisher E, Anderson B, LeGreca A, Marrero D, Johnson S, Rubin R, Cox D</AU>
<TI>Behavioural Science in Diabetes: Contributions and Opportunities</TI>
<SO>Diabetes Care</SO>
<YR>1999</YR>
<VL>22</VL>
<NO>5</NO>
<PG>832-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" MODIFIED="2008-10-31 14:25:46 +0100" MODIFIED_BY="Bernd Richter" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analysis</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2005" MODIFIED="2008-10-31 14:44:58 +0100" MODIFIED_BY="Bernd Richter" NAME="Higgins 2005" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]</TI>
<SO>In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley &amp; Sons, Ltd</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Holmes-2003" MODIFIED="2008-11-12 16:44:47 +0100" MODIFIED_BY="Bernd Richter" NAME="Holmes 2003" TYPE="JOURNAL_ARTICLE">
<AU>Holmes J, Gear E, Bottomley J, Gillam S, Murphy M, Williams R</AU>
<TI>Do people with type 2 diabetes and their carers lose income? (T2ARDIS-4)</TI>
<SO>Health Policy</SO>
<YR>2003</YR>
<VL>64</VL>
<NO>3</NO>
<PG>291-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jonsson-2002" NAME="Jonsson 2002" TYPE="JOURNAL_ARTICLE">
<AU>Jonsson B</AU>
<TI>Revealing the cost of Type II diabetes in Europe</TI>
<SO>Diabetologia</SO>
<YR>2002</YR>
<VL>45</VL>
<PG>S5-S12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-King-1998" NAME="King 1998" TYPE="JOURNAL_ARTICLE">
<AU>King H, Aubert R, Herman W</AU>
<TI>Global Burden of diabetes, 1995-2025 prevalence, numerical estimates and projections</TI>
<SO>Diabetes care</SO>
<YR>1998</YR>
<VL>21</VL>
<PG>1414-1431</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Loveman-2003" MODIFIED="2008-11-12 16:01:10 +0100" MODIFIED_BY="Bernd Richter" NAME="Loveman 2003" TYPE="COCHRANE_REVIEW">
<AU>Loveman E, Royle P, Waugh N</AU>
<TI>Specialist nurses in diabetes mellitus</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-11-12 15:57:51 +0100" MODIFIED_BY="Bernd Richter">
<IDENTIFIER MODIFIED="2008-11-12 15:57:51 +0100" MODIFIED_BY="Bernd Richter" TYPE="DOI" VALUE="10.1002/14651858.CD003286"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Loveman-2008" NAME="Loveman 2008" TYPE="JOURNAL_ARTICLE">
<AU>Loveman E, Frampton GK, Clegg AJ</AU>
<TI>The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review. The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review.</TI>
<SO>Health Technol Assess</SO>
<YR>Apr 2008</YR>
<VL>12</VL>
<NO>9</NO>
<PG>1-136</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1999" MODIFIED="2008-10-31 15:11:57 +0100" MODIFIED_BY="Bernd Richter" NAME="Moher 1999" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF</AU>
<TI>Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses</TI>
<SO>Lancet</SO>
<YR>1999</YR>
<VL>354</VL>
<NO>9193</NO>
<PG>1896-900</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Norris-2001" NAME="Norris 2001" TYPE="JOURNAL_ARTICLE">
<AU>Norris SL, Engelgau MM, Narayan KMV.</AU>
<TI>Effectiveness of self-management training in type 2 diabetes</TI>
<SO>Diabetes Care</SO>
<YR>2001</YR>
<VL>24</VL>
<NO>3</NO>
<PG>561-587</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Vermeire-2003" MODIFIED="2008-11-12 16:00:52 +0100" MODIFIED_BY="Bernd Richter" NAME="Vermeire 2003" TYPE="COCHRANE_REVIEW">
<AU>Vermeire E, Wens J, Van Royen P, Hernshaw H, Lindenmeyer A</AU>
<TI>Interventions for improving adherence to treatment recomendations in people with type 2 diabetes mellitus</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-11-12 16:00:52 +0100" MODIFIED_BY="Bernd Richter">
<IDENTIFIER MODIFIED="2008-11-12 16:00:52 +0100" MODIFIED_BY="Bernd Richter" TYPE="DOI" VALUE="10.1002/14651858.CD003638.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-WHO-1980" MODIFIED="2008-10-31 14:25:10 +0100" MODIFIED_BY="Bernd Richter" NAME="WHO 1980" TYPE="OTHER">
<TI>WHO Expert Committee on Diabetes Mellitus</TI>
<SO>Geneva: World Health Organisation, 1980. Second report. Technical Report Series 646</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1985" MODIFIED="2008-10-31 14:25:16 +0100" MODIFIED_BY="Bernd Richter" NAME="WHO 1985" TYPE="OTHER">
<TI>WHO Expert Committee on Diabetes Mellitus</TI>
<SO>Geneva: World Health Organization, 1985. Technical Report Series 727.</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-1998" MODIFIED="2008-10-31 14:25:19 +0100" MODIFIED_BY="Bernd Richter" NAME="WHO 1998" TYPE="JOURNAL_ARTICLE">
<AU>Alberti KM, Zimmet PZ</AU>
<TI>Definition, diagnosis and classification of diabetes mellitus and its compliactions. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation</TI>
<SO>Diabetic Medicine</SO>
<YR>1998</YR>
<VL>15</VL>
<PG>539-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wild-2004" NAME="Wild 2004" TYPE="JOURNAL_ARTICLE">
<AU>Wild S, Roglic G, Green A, Sicree R, King H</AU>
<TI>Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030</TI>
<SO>Diabetes Care</SO>
<YR>2004</YR>
<VL>27</VL>
<PG>1047-1053</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2008-11-21 12:09:55 +0100" MODIFIED_BY="Bernd Richter">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2008-10-31 11:37:34 +0100" MODIFIED_BY="Bernd Richter" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2008-10-31 11:28:27 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Campbell-1996">
<CHAR_METHODS MODIFIED="2008-10-31 11:28:26 +0100" MODIFIED_BY="Bernd Richter">
<P>Locale: New South Wales, Australia.<BR/>Method of recruitment: Patients referred to a Diabetes Education Service (DES).<BR/>Inclusion/exclusion criteria: Diagnosed with type 2 diabetes, diagnosed for &lt; 5 years, age &lt; 80 yrs, speak, read and understand English, no previous formal instruction on diabetes care, not taking over 75% of the maximum dosage of oral hyopoglycaemic agents and not terminally ill.<BR/>Randomisation: No details on concealed allocation or method used.<BR/>Length of follow-up from start of intervention: 6 and 12 months.<BR/>Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): No details given.<BR/>Power analysis: no<BR/>Intention to treat: no.<BR/>Informed consent: yes.<BR/>Approval: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Socio-economic background: Not given. Could be judged by referral to the DES. 74% had education up to lower high school.<BR/>Baseline numbers: Recruited = not given; Eligible= 252; Randomised= 238; Control (Minimal) = 59; Control (Group education) = 65; Intervention (Individual education) = 57; Intervention (Behavioral) = 56. <BR/>End of study numbers at 6 months: Control (Minimal) = 17; Control (Group education) = 27; Intervention (Individual education) = 29; Intervention (Behavioral) = 43. <BR/>End of study numbers at 12 months: Control (Group education) = 19; Intervention (Individual education) = 25; Intervention (Behavioral) = 39.<BR/>Dropout rate: overall at 6 months 53%, at 12 months 35%.<BR/>Age (mean or range): 58.6 years.<BR/>Ethnicity: not given.<BR/>Sex: 52.3 % females.<BR/>Number of years of diabetes: mean = 0.54 years.<BR/>Proportion of Type 2: all type 2.<BR/>Treatment given: 37% on oral hypoglycaemic medication.<BR/>Average HbA1: Individual 12.2% Group 12.1%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-31 11:28:27 +0100" MODIFIED_BY="Bernd Richter">
<P>The study reported four interventions involving diet, exercise, use of oral hypoglycaemic agents, urine testing, foot care and recommendations to consult opthalmologist and podiatrist.<BR/>1. Minimal (Control) - Two (nurse educator and dietician) 1- hr sessions. Same topics as intervention groups but in less detail.<BR/>2. Group education - Two 1-hr individual sessions + 3-day course in small groups + two 2-hr group follow up at 3 and 9 mo. Also opportunity to attend one 2-hr lecture.<BR/>3. Individual education - Two 1-hr individual sessions + approx. monthly for 12 months. Same topics but greater details. Opportunity to attend a 2-hr lecture.<BR/>4. Behavioral (Intervention) - series of individual visits by nurse educator + random phone calls by nurse educator. Emphasis on cognitive-behavioural strategies and cardiovascular risks (diet, exercise and smoking).<BR/>At 6 months, Extensive and Behavioural were compared with Minimal program as control. For 12-month comparison, Extensive Group was used as control in this review as there were no outcome reported for Minimal Program.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>HbA1, BMI kg/m2; fasting total cholesterol, mmol/l; HDL , mmol/l; cholesterol risk ratio ( total cholesterol /HDL); systolic BP, mmHg; diastolic BP, mmHg; knowledge test (DKN), 15-point scale; satisfaction ,18 item scale developed by authors.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-31 11:19:33 +0100" MODIFIED_BY="Bernd Richter">
<P>Group education had components in individual sessions. Group patients received more overall contact than all other groups. Participants in Minimal program were not measured at 12 months. Therefore for analysis only individual and group were used</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-10-31 11:28:29 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Dalmau-2003">
<CHAR_METHODS>
<P>Locale: Spain<BR/>Method of recruitment: Patients from primary care.<BR/>Inclusion/exclusion criteria: Diagnosed with type 2 diabetes at least six months before the start of trial and had not received group education. Those over 75 years, or having sensory psychological and/or physical deficiencies and those not monitored in primary care were excluded.<BR/>Randomisation: Unsure of concealment or method used.<BR/>Length of follow-up from start of intervention: 12 months.<BR/>Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): unsure.<BR/>Power analysis: unsure.<BR/>Intention to treat: no.<BR/>Informed consent: unsure.<BR/>Approval: unsure.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-31 11:28:29 +0100" MODIFIED_BY="Bernd Richter">
<P>Socio-economic background: Unsure.<BR/>Baseline numbers: Recruited = 93; Eligible= 79; Randomised= 79; group= 38; Individual = 41.<BR/>End of study numbers: group= 35; Individual= 33.<BR/>Dropout rate: 14%.<BR/>Age: mean = 65 years.<BR/>Ethnicity: unclear.<BR/>Sex: 35% males in individual education and 64.7% males in group education<BR/>Number of years of diabetes: diagnosed at least 6 months prior to study<BR/>Proportion of Type 2: all.<BR/>Oral hypoglycaemics: individual 60% and group 51.4%<BR/>Average HbA1c at baseline: Intervention - 6.6% and group 7.2%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Control: Group education.<BR/>Intervention: Individual education.<BR/>Each received 3 sessions, seperated by one week, 40 minutes, content the same</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>HbA1c%; HDL cholesterol, mmol/l; LDL cholesterol, mmol/l; BMI, kg/m2; systolic BP, mmHg; diastolic BP, mmHg; diabetes knowledge.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>There were almost twice as many women in Intervention group compared to that in Control group. Published in Spanish. Data extracted from summary, text and tables.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-10-31 11:28:30 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Goudswaard-2004">
<CHAR_METHODS>
<P>Locale: The Netherlands<BR/>Method of recruitment: Recruited from 57 practices, 78 GPs<BR/>Inclusion/exclusion criteria: Type 2 diabetes, treated by primary care only, aged less than 76 years, with HbA1c &gt;= 7.0% while taking the maximum feasible dosages of two different oral hypoglycaemic agents. Excluded are those with severe co-morbidity, not fluent in Dutch, requirement for insulin therapy in the short term on account of severe hyperglycaemic symptoms.<BR/>Randomisation: By independent trial centre. Method used was computer-generated random assignment with blocks of 8 patients at a time.<BR/>Length of follow-up from start of intervention: 6 and 18 months<BR/>Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)):<BR/>Power analysis: yes<BR/>Intention to treat: yes; missing values represented last previous value.<BR/>Informed consent: yes<BR/>Approval: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-31 11:19:44 +0100" MODIFIED_BY="Bernd Richter">
<P>Socio-economic background: Participants from all levels of community.<BR/>Sampling: Recruitment to randomisation =76.3%. Randomisation to completion of trial = 86.2%.<BR/>Baseline numbers: Recruited = 1810; Eligible = 76; Randomised = 58; Control = 30; Intervention = 28.<BR/>End of study numbers: Control = 26; Intervention = 24.<BR/>Dropout rate: 14%<BR/>Age: average = 60.5 years<BR/>Ethnicity: Dutch<BR/>Sex: 52 % females<BR/>Number of years of diabetes: 7.5 years.<BR/>Proportion of Type 2: all.<BR/>Medication: 22% on diet only, 12% on insulin,66% oral hypoglycaemic agents.<BR/>Average HbA1c - Intervention 8.2%, Control 8.8%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-31 11:28:30 +0100" MODIFIED_BY="Bernd Richter">
<P>Intervention: Collaborative, mixed educational intervention by two diabetes nurses. Focus on diabetes, compliance with medication, importance of physical exercise, losing weight and nutritional advice. 6 sessions during the 6 month period, total contact time of approximately 2.5 hours</P>
<P>Control: Usual care by GP. GP instructed not to alter medication unless a patient developed severe hyperglycaemic symptoms</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>HbA1c, %. body weight</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR STUDY_ID="STD-Hawthorne-1997">
<CHAR_METHODS>
<P>Locale: UK. <BR/>Method of recruitment: Recruited through Manchester Diabetes Centre or one of 10 mini-clinics.<BR/>Inclusion/exclusion criteria: British Pakistanis with Type 2 diabetes. Excluded if enrolled in another study, too ill, if they or spouse had received formal education in the last 6 months<BR/>Randomisation: Sequential and using concealed envelope and random number generator.<BR/>Length of follow-up from start of intervention: 6 months<BR/>Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): unclear<BR/>Power analysis: yes<BR/>Intention to treat: no<BR/>Informed consent: yes<BR/>Approval: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Socio-economic background: Pakistani migrant and many with little knowledge of English and many illiterate.<BR/>Baseline numbers: Recruited = na; Eligible= na; Randomised= 201; Control= 112; Intervention = 89. <BR/>End of study numbers: Control= 86; Intervention= 106.<BR/>Return to follow-up rate: 95%<BR/>Age (mean or range): Intervention 52 years, control 54 years<BR/>Ethnicity: Pakistani<BR/>Sex: 46% males in intervention and 47% male in control group<BR/>Number of years of diabetes: unknown.<BR/>Proportion of Type 2: all.<BR/>HbA1c: Intervention 8.4% and control 8.6%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Intervention: Face-to-face by diabetes nurse using flash cards on various topics (diabetic diet, glucose monitoring and diabetic complications). The educational services were offered in Punjabi or Urudu. 20 minutes with each patient</P>
<P>Control: usual care.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>HbA1c, %; knowledge on complications; food knowledge score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-10-31 11:37:12 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Hiss-2001">
<CHAR_METHODS>
<P>Locale: USA.<BR/>Method of recruitment: Through advertisements and announcement with offer of free &amp; comprehensive diabetes evaluation. Two large and 2 small communities were targeted based on area codes.<BR/>Inclusion/exclusion criteria: Diagnosed with diabetes Type 2, and those with Type 1 were excluded.<BR/>Randomisation: No indication of concealed allocation but random number used.<BR/>Length of follow-up from start of intervention: 12 months.<BR/>Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): not blinded.<BR/>Power analysis: no<BR/>Intention to treat: no<BR/>Informed consent: yes<BR/>Approval: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Socio-economic background: Those who responded to the advertisement for the service or incentive or both.<BR/>Baseline numbers: Recruited = 431; Eligible= 376; Randomised= 376; Control= 190; Intervention = 186. <BR/>End of study numbers: Control= 156; Intervention= 158.<BR/>Return to follow-up rate: 84%<BR/>Age (mean or range): Control = 64 years; Intervention = 65 years.<BR/>Ethnicity: not available<BR/>Sex: Control = 27% and Intervention = 12% females.<BR/>Number of years of diabetes: Control = 10 years and Intervention = 9 years.<BR/>Proportion of Type 2: all.<BR/>Average HbA1c: Intervention 7.7% &amp; control 7.9%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Control: usual care.<BR/>Intervention: Face-to-face or via telephone by specialist nurse educator. Approx 4 hours of professional time per patient<BR/>Individual education and counselling session to encourage the patient to consult physician about identified problem.<BR/>High risk subsets for each outcome were defined as follows: HbA1c &gt;= 7.5%, cholesterol &gt;= 6.22mmol/l, systolic blood pressure &gt;= 140 mmHg and systolic blood pressure &gt;= 90 mmHg.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-31 11:37:12 +0100" MODIFIED_BY="Bernd Richter">
<P>HbA1c, %; total cholesterol, mmol/L; diastolic BP, mmHg; systolic BP, mmHg.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>intervention timing not clear;</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-10-31 11:37:15 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Ko--2004">
<CHAR_METHODS>
<P>Locale: Hong Kong<BR/>Method of recruitment: from 3 regional diabetic centres in Hong Kong<BR/>Inclusion/exclusion criteria: HbA1c 8.1 - 11%, age range 35 - 70 years<BR/>Randomisation: coin tossing<BR/>Length of follow-up from start of intervention: 1 year<BR/>Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): physicians blinded<BR/>Power analysis: yes<BR/>Intention to treat: no<BR/>Informed consent: not stated<BR/>Approval: not stated</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-31 11:37:15 +0100" MODIFIED_BY="Bernd Richter">
<P>Socio-economic background:<BR/>Baseline numbers: 90 in each group<BR/>End of study numbers: 2 control patients defaulted follow-up<BR/>Return to follow-up rate: 99%<BR/>Age (mean or range): Intervention 55, control 56 years<BR/>Ethnicity: Chinese<BR/>Sex: Intervention 48.9% male, control group 38.6% male<BR/>Number of years of diabetes: not stated<BR/>Proportion of Type 2: all.<BR/>Average HbA1c: Intervention 8.6%, control 8.4%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Both groups followed up every 10 - 14 weeks<BR/>Intervention: 5 x 30 minute visits after follow-up by physicians, by nurse educator, concentrated on CV risk factors<BR/>Control: same medical care except no nursing reinforcement</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>fasting glucose, HbA1c, body mass index, waist circumference, blood pressure and lipid profiles</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-10-31 11:37:24 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Rickheim-2002">
<CHAR_METHODS>
<P>Locale: USA.<BR/>Method of recruitment: Patients referred to Diabetes Centre by primary care provider over a 2-year period from April 1997 to July 1999. <BR/>Inclusion/exclusion criteria: Type 2. Newly diagnosed or previously diagnosed but without prior formal diabetes education. Patients treated with medical nutritional therapy and /or medical therapy.<BR/>Randomisation: randomisation in blocks of 3 patients to Control or Intervention during first year and in the following year, in blocks of 10 patients. Method of concealment or allocation was unclear.<BR/>Length of follow-up from start of intervention: 6 months.<BR/>Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): all unclear.<BR/>Power analysis: not presented.<BR/>Intention to treat: no.<BR/>Informed consent: yes<BR/>Approval: yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Source of patients: referred by primary care providers. Newly diagnosed diabetes or no history of prior systematic diabetes education<BR/>Socio-economic background: not clear.<BR/>Baseline numbers: Randomised= 170; Control= 87; Intervention = 83. <BR/>End of study numbers: Control= 43; Intervention= 49.<BR/>Retention to follow-up: 54%<BR/>Age (mean or range): 52.5 years<BR/>Ethnicity: 93% Caucasians<BR/>Sex: 66% females<BR/>Number of years of diabetes: 0.9 years.<BR/>Proportion of Type 2: All<BR/>Average HbA1c: Group 9% and individual 8.2%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-31 11:37:17 +0100" MODIFIED_BY="Bernd Richter">
<P>General: Four sessions were given to both groups. 5-7 hours. Contents covered topics on education including diet, glucose monitoring and foot care. Participants in control groups received in groups of 4 to 8. Individuals in intervention group had shorter sessions to cover the same material. Interventions in both settings emphasized empowering the patient, by increasing knowledge, facilitating self-management behaviour change</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>HbA1c, %; weight, kg; BMI, kg/m2; knowledge test (14pts); exercise (times/week); exercise duration (min/week); ATT-19 - Psychosocial adjustment and attitudes towards diabetes using 19-point score; SF-36 mental scale that measured mental health related quality of life; SF-36 physical scale that measured physical health related quality of life.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-10-31 11:37:24 +0100" MODIFIED_BY="Bernd Richter">
<P>Allocation in blocks of 6 or 10 may be biased. Groups attending clinic may be relatives, friends of similar socio-economic background.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-10-31 11:37:31 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Shibayama-2007">
<CHAR_METHODS>
<P>Locale: Japan<BR/>Method of recruitment: outpatients of Department of diabetes and Metabolism, University Hospital.<BR/>Inclusion/exclusion criteria: adults, between ages of 20 - 75, diagnosed with type 2 diabetes; HbA1c between 6.5% and 8.5%, who could not use insulin. <BR/>Randomisation: randomised but no details on concealment or methods.<BR/>Length of follow-up from start of intervention: 1 year<BR/>Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): not blinded.<BR/>Power analysis: yes with 64 patients in each group, there was an 80% power to detect 0.5% difference in the change in HbA1c<BR/>Intention to treat: no.<BR/>Informed consent: not stated<BR/>Approval: Yes</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Socio-economic background: not stated<BR/>Baseline numbers: intervention 67 and control 67<BR/>End of study numbers at 12 months: intervention 59 control 61<BR/>Dropout rate: 10%<BR/>Age (mean or range): Intervention 61, Control 62<BR/>Ethnicity: Japanese<BR/>Sex: 65% males<BR/>Number of years of diabetes: mean = intervention 10 years, control 13 years.<BR/>Proportion of Type 2: all.<BR/>Treatment given: 89.6% on oral hypoglycaemic medication in intervention and 82.1% in control<BR/>Average HbA1c: Individual 7.3% Group 7.4%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2008-10-31 11:37:30 +0100" MODIFIED_BY="Bernd Richter">
<P>Intervention: received normal medical consultation and one-to-one counselling with a certified expert nurse at monthly hospital visits for 1 year. Features are patient participation in goal setting, personalized strategies and goal setting.<BR/>Control: received usual care by same practitioners at hospital clinic</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-10-31 11:37:31 +0100" MODIFIED_BY="Bernd Richter">
<P>HbA1c, HRQOL with SF-36Japanese Version, PAID , cognitive modification (3 items), behavioural modification (1 item) and overall satisfaction with counselling (1 item)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2008-10-31 11:37:34 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Whittemore-2004">
<CHAR_METHODS>
<P>Locale: USA.<BR/>Method of recruitment: Patients enrolled at single diabetes centre.<BR/>Inclusion/exclusion criteria: Females, diagnosed with type 2 diabetes; 30 to 70 yrs age; cleared for exercise by primary care provider; had no advanced complications of diabetes; HbA1c &gt;7%; fluent in English and had previously participated in diabetes education.<BR/>Randomisation: randomised but no details on concealment or methods.<BR/>Length of follow-up from start of intervention: 6 months.<BR/>Blinding (Investigator (I), Patient (P), Evaluator (E), Analyst (A)): all unclear.<BR/>Power analysis: no.<BR/>Intention to treat: no.<BR/>Informed consent: yes.<BR/>Approval: yes.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2008-10-31 11:37:34 +0100" MODIFIED_BY="Bernd Richter">
<P>Socio-economic background: wide cover, low to middle income, mean of 12.6 yrs of education.<BR/>Baseline numbers: Recruited = 81; Eligible= 53; Randomised= 53; Control= 24; Intervention = 29.<BR/>End of study numbers: Control= 23; Intervention= 26.<BR/>Retention to follow-up rate: 92%<BR/>Age (mean or range): 57.6 years<BR/>Ethnicity: 89% white, 11% Hispanic.<BR/>Sex: all females<BR/>Number of years of diabetes: 2.7 years.<BR/>Proportion of Type 2: all.<BR/>Mean HbA1c 7.7%</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Control: standard diabetes care at 3 - 4 month intervals. Providers nurse practitioners, internists, endocrinologists and family practice specialists<BR/>Intervention: Individualised 6 nurse-coaching sessions over 6 months. Included topics were assessment, education reinforcement (cognitive component), problem solving (behavioural component) and psychosocial support (affective component).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>HbA1c, %; BMI, kg/m2; self management on diet, 5-point scale; self management on exercise, min/mo; distress- PAID score; integration - TDQ score., treatment satisfaction DTSQc</P>
<P>HbA1c DCA 2000 analyzer</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2008-11-21 12:09:55 +0100" MODIFIED_BY="Bernd Richter" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Aas--2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Anderson---2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:49:49 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Bacardi_x002d_Gascon--2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:49:49 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Baradaran--2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:49:56 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Baran--1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:49:56 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Barcelo--2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed type 1/ type 2</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Barth--1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bloomgarden-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bradshaw--2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:50:02 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Browning--2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:50:02 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cabrera_x002d_Pivaral-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chen--2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily foot care intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:50:07 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Cleghorn---2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:50:07 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Clifford--2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Managed care - pharmacy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cooper--2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-D_x0027_Eramo_x002d_Melkus-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-De-Weerdt_x002c_-I._x002c_-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:50:22 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Deakin--2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:50:22 +0100" MODIFIED_BY="Bernd Richter">
<P>Control group non standardized individual education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Di--Loreto--2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily physical activity intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dijkstra--2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Education of professionals</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dongbo-2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Donohoe--2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>Education of professionals</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fan--1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:50:52 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Fan_x002c_-M.-J._x002c_-G.-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:50:52 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fornos--2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Managed care - pharmacy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fu--2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Fukuda-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gabbay---2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Managed care</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gaede--2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gallegos-2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gary--2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Managed care</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gentile--2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ghosh--2007">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:51:00 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Gilliland--2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:51:00 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Glasgow">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hae---2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Managed care - pharmacy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:51:08 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Hajdinjak--2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:51:08 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hanefeld--1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Holtrop--2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:51:14 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Jayasuriya---2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:51:14 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Jones---2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Education not face to face</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:51:23 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Jungmann---1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:51:23 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kirk--2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily physical activity intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ko_x002c_-S.-H._x002c_-K.--2007">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Korhonen--1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily dietary intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:51:28 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Kronsbein---1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:51:28 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kulzer---2007">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Laitinen-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily dietary intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Li---2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:51:41 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Li_x002c_-X._x002c_-Y.-Cao_x002c_-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:51:41 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Litzelman-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not individual education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lorig---2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not specific for diabetes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lou---2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Lozano--1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Maislos---2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Managed care</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Martinus----2006">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily physical activity intervention</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mayer_x002d_Davis--2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mazzuca---1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mshelia----2007">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 14:37:17 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Neder----2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 14:37:17 +0100" MODIFIED_BY="Bernd Richter">
<P>References 'Corbett 2003' which evaluated foot care</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Odegard----2005">
<CHAR_REASON_FOR_EXCLUSION>
<P>Managed care - pharmacy</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pedersen----2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Pennings_x002d_Van----1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Philis_x002d_Tsimikas-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Mixed individual and group education sessions</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-10-31 12:52:16 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Pibernik_x002d_Okanovi2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-10-31 12:52:16 +0100" MODIFIED_BY="Bernd Richter">
<P>Not a randomised controlled trial/ controlled trial, group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2008-11-21 12:09:55 +0100" MODIFIED_BY="Bernd Richter" STUDY_ID="STD-Trento-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2008-11-21 12:09:55 +0100" MODIFIED_BY="Bernd Richter">
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wilson---1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wolf-----2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>Primarily group education</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Woollard--2003">
<CHAR_REASON_FOR_EXCLUSION>
<P>Not specific to diabetes</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Campbell-1996">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Dalmau-2003">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Goudswaard-2004">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Hawthorne-1997">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="YES" STUDY_ID="STD-Hiss-2001">
<DESCRIPTION>
<P>A - Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Ko--2004">
<DESCRIPTION>
<P>D - Not used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Rickheim-2002">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Shibayama-2007">
<DESCRIPTION>
<P>B - Unclear</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="NO" STUDY_ID="STD-Whittemore-2004">
<DESCRIPTION>
<P>C - Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-08-13 11:09:32 +0200" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2008-11-21 12:26:16 +0100" MODIFIED_BY="Bernd Richter">
<COMPARISON ID="CMP-001" MODIFIED="2008-11-21 12:25:53 +0100" MODIFIED_BY="Bernd Richter" NO="1">
<NAME>Individual diabetes education programme versus usual care</NAME>
<CONT_OUTCOME CHI2="2.368802185876304" CI_END="0.0305333156747373" CI_START="-0.49058025855546616" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.23002347144036442" ESTIMABLE="YES" I2="15.569142416164699" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2008-11-21 12:25:08 +0100" MODIFIED_BY="Bernd Richter" NO="1" P_CHI2="0.30592940255288414" P_Q="0.3976698445608462" P_Z="0.08357921793096826" Q="0.7153623969312988" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="157" TOTAL_2="138" UNITS="" WEIGHT="100.00000000000001" Z="1.7302858413848692">
<NAME>HbA1c: 6 - 9 months (r = 0.75)</NAME>
<GROUP_LABEL_1>Individual Education</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.6534397889450054" CI_END="0.01721216968465511" CI_START="-0.6717247829781123" DF="1.0" EFFECT_SIZE="-0.3272563066467286" ESTIMABLE="YES" I2="39.52002324571731" ID="CMP-001.01.01" NO="1" P_CHI2="0.19849147199918282" P_Z="0.06259888716486249" STUDIES="2" TAU2="0.0" TOTAL_1="131" TOTAL_2="115" WEIGHT="57.214461221745864" Z="1.8620298193096128">
<NAME>Both Sexes</NAME>
<CONT_DATA CI_END="-0.06010392121380059" CI_START="-1.1398960787861994" EFFECT_SIZE="-0.6" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="-0.4" ORDER="133" SD_1="0.87" SD_2="1.15" SE="0.2754622447375721" STUDY_ID="STD-Goudswaard-2004" TOTAL_1="25" TOTAL_2="29" WEIGHT="23.290801511231752"/>
<CONT_DATA CI_END="0.3073537078511556" CI_START="-0.5873537078511557" EFFECT_SIZE="-0.14" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="0.04" ORDER="134" SD_1="1.68" SD_2="1.48" SE="0.2282458817507998" STUDY_ID="STD-Hawthorne-1997" TOTAL_1="106" TOTAL_2="86" WEIGHT="33.92365971051411"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.2983399713175965" CI_START="-0.49833997131759644" DF="0.0" EFFECT_SIZE="-0.1" ESTIMABLE="YES" I2="0.0" ID="CMP-001.01.02" NO="2" P_CHI2="1.0" P_Z="0.6226960392692262" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="23" WEIGHT="42.78553877825415" Z="0.49203296823490883">
<NAME>Women</NAME>
<CONT_DATA CI_END="0.2983399713175965" CI_START="-0.49833997131759644" EFFECT_SIZE="-0.1" ESTIMABLE="YES" MEAN_1="-0.2" MEAN_2="-0.1" ORDER="135" SD_1="0.71" SD_2="0.71" SE="0.20323841379721838" STUDY_ID="STD-Whittemore-2004" TOTAL_1="26" TOTAL_2="23" WEIGHT="42.78553877825415"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="4.327836288727335" CI_END="0.08337282788265524" CI_START="-0.24841375451847328" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.08252046331790902" ESTIMABLE="YES" I2="30.6812966143367" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2008-11-21 12:25:17 +0100" MODIFIED_BY="Bernd Richter" NO="2" P_CHI2="0.2281708347301803" P_Q="1.0" P_Z="0.3295866542860727" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="318" TOTAL_2="314" UNITS="" WEIGHT="99.99999999999999" Z="0.9749468162345448">
<NAME>HbA1c: 12 - 18 months (r = 0.75)</NAME>
<GROUP_LABEL_1>Individual Education</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.6919783395880021" CI_START="-0.2919783395880022" EFFECT_SIZE="0.19999999999999996" ESTIMABLE="YES" MEAN_1="-0.4" MEAN_2="-0.6" ORDER="136" SD_1="0.73" SD_2="1.03" SE="0.2510139693732459" STUDY_ID="STD-Goudswaard-2004" TOTAL_1="24" TOTAL_2="26" WEIGHT="11.370136585921042"/>
<CONT_DATA CI_END="0.17673400399341427" CI_START="-0.3767340039934142" EFFECT_SIZE="-0.09999999999999998" ESTIMABLE="YES" MEAN_1="-0.3" MEAN_2="-0.2" ORDER="137" SD_1="1.17" SD_2="1.15" SE="0.14119341282608086" STUDY_ID="STD-Hiss-2001" TOTAL_1="137" TOTAL_2="133" WEIGHT="35.93623652025309"/>
<CONT_DATA CI_END="3.631443694512848E-4" CI_START="-0.6003631443694513" EFFECT_SIZE="-0.3" ESTIMABLE="YES" MEAN_1="-0.5" MEAN_2="-0.2" ORDER="138" SD_1="1.1" SD_2="0.94" SE="0.15324931822149662" STUDY_ID="STD-Ko--2004" TOTAL_1="90" TOTAL_2="88" WEIGHT="30.504531715830968"/>
<CONT_DATA CI_END="0.4521754083163235" CI_START="-0.25217540831632346" EFFECT_SIZE="0.1" ESTIMABLE="YES" MEAN_1="0.1" MEAN_2="0.0" ORDER="139" SD_1="1.04" SD_2="1.04" SE="0.17968463252092293" STUDY_ID="STD-Shibayama-2007" TOTAL_1="67" TOTAL_2="67" WEIGHT="22.18909517799489"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.047158202089478" CI_END="0.1617757217439762" CI_START="-0.6916668480908683" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.2649455631734461" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2008-11-21 12:25:27 +0100" MODIFIED_BY="Bernd Richter" NO="3" P_CHI2="0.5923965902785027" P_Q="0.5457906692564342" P_Z="0.2236363760866067" Q="0.36491272576364664" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="157" TOTAL_2="138" UNITS="" WEIGHT="100.0" Z="1.216915537232051">
<NAME>HbA1c: 6 - 9 months (r = 0.25)</NAME>
<GROUP_LABEL_1>Individual Education</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6822454763258314" CI_END="0.1759516756695345" CI_START="-0.9155777471001512" DF="1.0" EFFECT_SIZE="-0.3698130357153083" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.01" NO="1" P_CHI2="0.4088149394596914" P_Z="0.18415105452720376" STUDIES="2" TAU2="0.0" TOTAL_1="131" TOTAL_2="115" WEIGHT="61.13328169491686" Z="1.3280818929759026">
<NAME>Both Sexes</NAME>
<CONT_DATA CI_END="0.1721417529663536" CI_START="-1.3721417529663535" EFFECT_SIZE="-0.6" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="-0.4" ORDER="140" SD_1="1.48" SD_2="1.4" SE="0.3939571130168254" STUDY_ID="STD-Goudswaard-2004" TOTAL_1="25" TOTAL_2="29" WEIGHT="30.54179358597376"/>
<CONT_DATA CI_END="0.6315143429544817" CI_START="-0.9115143429544817" EFFECT_SIZE="-0.14" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="0.04" ORDER="141" SD_1="2.9" SD_2="2.55" SE="0.39363699998575913" STUDY_ID="STD-Hawthorne-1997" TOTAL_1="106" TOTAL_2="86" WEIGHT="30.591488108943096"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.5844715000105178" CI_START="-0.7844715000105178" DF="0.0" EFFECT_SIZE="-0.1" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.02" NO="2" P_CHI2="1.0" P_Z="0.7746123216618159" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="23" WEIGHT="38.86671830508315" Z="0.28634705528425025">
<NAME>Women</NAME>
<CONT_DATA CI_END="0.584471500010518" CI_START="-0.7844715000105179" EFFECT_SIZE="-0.1" ESTIMABLE="YES" MEAN_1="-0.2" MEAN_2="-0.1" ORDER="142" SD_1="1.22" SD_2="1.22" SE="0.3492265701867696" STUDY_ID="STD-Whittemore-2004" TOTAL_1="26" TOTAL_2="23" WEIGHT="38.86671830508315"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.0614243776650243" CI_END="0.14376989083224526" CI_START="-0.24634885044748997" CI_STUDY="95" CI_TOTAL="95" DF="3.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.05128947980762235" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2008-11-21 12:25:34 +0100" MODIFIED_BY="Bernd Richter" NO="4" P_CHI2="0.5597562526862445" P_Q="1.0" P_Z="0.6063024264237206" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="318" TOTAL_2="314" UNITS="" WEIGHT="99.99999999999999" Z="0.5153586463391778">
<NAME>HbA1c: 12 - 18 months (r = 0.25)</NAME>
<GROUP_LABEL_1>Individual Education</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.0451245728326506" CI_START="-0.6451245728326508" EFFECT_SIZE="0.19999999999999996" ESTIMABLE="YES" MEAN_1="-0.4" MEAN_2="-0.6" ORDER="143" SD_1="1.24" SD_2="1.78" SE="0.4311939298369182" STUDY_ID="STD-Goudswaard-2004" TOTAL_1="24" TOTAL_2="26" WEIGHT="5.327116301486246"/>
<CONT_DATA CI_END="0.17673400399341427" CI_START="-0.3767340039934142" EFFECT_SIZE="-0.09999999999999998" ESTIMABLE="YES" MEAN_1="-0.3" MEAN_2="-0.2" ORDER="144" SD_1="1.17" SD_2="1.15" SE="0.14119341282608086" STUDY_ID="STD-Hiss-2001" TOTAL_1="137" TOTAL_2="133" WEIGHT="49.683088283131305"/>
<CONT_DATA CI_END="0.21559355204938663" CI_START="-0.8155935520493867" EFFECT_SIZE="-0.3" ESTIMABLE="YES" MEAN_1="-0.5" MEAN_2="-0.2" ORDER="145" SD_1="1.9" SD_2="1.6" SE="0.26306276855917904" STUDY_ID="STD-Ko--2004" TOTAL_1="90" TOTAL_2="88" WEIGHT="14.312604885711497"/>
<CONT_DATA CI_END="0.4521754083163235" CI_START="-0.25217540831632346" EFFECT_SIZE="0.1" ESTIMABLE="YES" MEAN_1="0.1" MEAN_2="0.0" ORDER="146" SD_1="1.04" SD_2="1.04" SE="0.17968463252092293" STUDY_ID="STD-Shibayama-2007" TOTAL_1="67" TOTAL_2="67" WEIGHT="30.67719052967094"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.05" MODIFIED="2008-11-21 12:25:44 +0100" MODIFIED_BY="Bernd Richter" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="26" TOTAL_2="23" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>BMI: 6 - 9 months (r = 0.75)</NAME>
<GROUP_LABEL_1>Individual</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" ID="CMP-001.05.01" NO="1" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="26" TOTAL_2="23" WEIGHT="0.0" Z="0.0">
<NAME>Women</NAME>
<CONT_DATA CI_END="2.7096669962937394" CI_START="-2.7096669962937394" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.3" MEAN_2="0.3" ORDER="147" SD_1="4.69" SD_2="4.95" SE="1.3825085652936722" STUDY_ID="STD-Whittemore-2004" TOTAL_1="26" TOTAL_2="23" WEIGHT="0.0"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2008-10-31 16:49:50 +0100" MODIFIED_BY="Bernd Richter" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="SUB" TOTAL_1="157" TOTAL_2="155" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>BMI: 12 - 18 months (r = 0.75)</NAME>
<GROUP_LABEL_1>Individual Education</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.5894875949619398" CI_START="-0.9894875949619397" EFFECT_SIZE="-0.2" ESTIMABLE="YES" MEAN_1="-0.2" MEAN_2="0.0" ORDER="148" SD_1="2.61" SD_2="2.76" SE="0.4028071950246623" STUDY_ID="STD-Ko--2004" TOTAL_1="90" TOTAL_2="88" WEIGHT="0.0"/>
<CONT_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" MEAN_1="0.0" MEAN_2="0.0" ORDER="149" SD_1="0.0" SD_2="0.0" SE="0.0" STUDY_ID="STD-Shibayama-2007" TOTAL_1="67" TOTAL_2="67" WEIGHT="0.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.0619198497104017" CI_END="0.9546646236923289" CI_START="-4.682829916258767" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.8640826462832194" ESTIMABLE="YES" I2="3.003019235645767" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2008-11-21 12:25:53 +0100" MODIFIED_BY="Bernd Richter" NO="7" P_CHI2="0.35666457213178904" P_Q="1.0" P_Z="0.19492190820318905" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="315" TOTAL_2="310" UNITS="" WEIGHT="100.0" Z="1.2961555261933506">
<NAME>Systolic blood pressure: 12 - 18 months (r = 0.75)</NAME>
<GROUP_LABEL_1>Individual education</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.2514829497098541" CI_START="-10.851482949709855" EFFECT_SIZE="-5.3" ESTIMABLE="YES" MEAN_1="-6.3" MEAN_2="-1.0" ORDER="150" SD_1="26.4" SD_2="23.66" SE="2.832441306829739" STUDY_ID="STD-Hiss-2001" TOTAL_1="158" TOTAL_2="155" WEIGHT="25.780673370567428"/>
<CONT_DATA CI_END="2.9954829581275955" CI_START="-4.995482958127596" EFFECT_SIZE="-1.0" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="0.0" ORDER="151" SD_1="14.07" SD_2="13.12" SE="2.0385491721498226" STUDY_ID="STD-Ko--2004" TOTAL_1="90" TOTAL_2="88" WEIGHT="49.770695764314574"/>
<CONT_DATA CI_END="5.700708926809024" CI_START="-5.700708926809024" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="2.0" MEAN_2="2.0" ORDER="152" SD_1="18.79" SD_2="14.62" SE="2.908578408468466" STUDY_ID="STD-Shibayama-2007" TOTAL_1="67" TOTAL_2="67" WEIGHT="24.44863086511799"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.877803903522866" CI_END="0.002769738328264326" CI_START="-3.2194706097112595" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-1.6083504356914975" ESTIMABLE="YES" I2="48.42441624799383" I2_Q="0.0" ID="CMP-001.08" MODIFIED="2008-11-12 17:36:33 +0100" MODIFIED_BY="Bernd Richter" NO="8" P_CHI2="0.14386197683714474" P_Q="1.0" P_Z="0.05039515800282237" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="315" TOTAL_2="309" UNITS="" WEIGHT="100.0" Z="1.9565945354713026">
<NAME>Diastolic blood pressure: 12 - 18 months (r = 0.75)</NAME>
<GROUP_LABEL_1>Individual education</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.3907416786526885" CI_START="-3.990741678652688" EFFECT_SIZE="-0.7999999999999998" ESTIMABLE="YES" MEAN_1="-2.4" MEAN_2="-1.6" ORDER="153" SD_1="13.83" SD_2="14.89" SE="1.6279593420189613" STUDY_ID="STD-Hiss-2001" TOTAL_1="158" TOTAL_2="154" WEIGHT="25.496031148332662"/>
<CONT_DATA CI_END="-0.8021548071927764" CI_START="-5.197845192807224" EFFECT_SIZE="-3.0" ESTIMABLE="YES" MEAN_1="-3.0" MEAN_2="0.0" ORDER="154" SD_1="7.48" SD_2="7.48" SE="1.121370193607406" STUDY_ID="STD-Ko--2004" TOTAL_1="90" TOTAL_2="88" WEIGHT="53.735546875537736"/>
<CONT_DATA CI_END="4.5352992911754" CI_START="-2.535299291175401" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="4.0" MEAN_2="3.0" ORDER="155" SD_1="10.44" SD_2="10.44" SE="1.8037572726138797" STUDY_ID="STD-Shibayama-2007" TOTAL_1="67" TOTAL_2="67" WEIGHT="20.7684219761296"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="2.6753117461182963" CI_END="0.10185041198440956" CI_START="-0.16000839321426943" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.029078990614929932" ESTIMABLE="YES" I2="25.242357160735747" I2_Q="0.0" ID="CMP-001.09" NO="9" P_CHI2="0.2624603693909988" P_Q="1.0" P_Z="0.6633435477985732" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="315" TOTAL_2="312" UNITS="" WEIGHT="100.0" Z="0.43530156848304774">
<NAME>Total cholesterol: 12 - 18 months</NAME>
<GROUP_LABEL_1>Individual education</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual Care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.04673777033378962" CI_START="-0.4267377703337896" EFFECT_SIZE="-0.19" ESTIMABLE="YES" MEAN_1="-0.25" MEAN_2="-0.06" ORDER="156" SD_1="1.01" SD_2="1.13" SE="0.12078679618663758" STUDY_ID="STD-Hiss-2001" TOTAL_1="158" TOTAL_2="157" WEIGHT="30.587167871443032"/>
<CONT_DATA CI_END="0.24820871025108898" CI_START="-0.1282087102510891" EFFECT_SIZE="0.05999999999999994" ESTIMABLE="YES" MEAN_1="-0.64" MEAN_2="-0.7" ORDER="157" SD_1="0.62" SD_2="0.66" SE="0.09602661668053869" STUDY_ID="STD-Ko--2004" TOTAL_1="90" TOTAL_2="88" WEIGHT="48.39438056801978"/>
<CONT_DATA CI_END="0.2855859431623017" CI_START="-0.2855859431623017" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.1" MEAN_2="0.1" ORDER="158" SD_1="1.0" SD_2="0.65" SE="0.14570979130992567" STUDY_ID="STD-Shibayama-2007" TOTAL_1="67" TOTAL_2="67" WEIGHT="21.018451560537194"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.6671026140880079" CI_END="-0.08538565631508219" CI_START="-0.5381594470574355" CI_STUDY="95" CI_TOTAL="95" DF="2.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.31177255168625884" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.10" NO="10" P_CHI2="0.4345037414199646" P_Q="1.0" P_Z="0.006950688509321151" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="221" TOTAL_2="203" UNITS="" WEIGHT="100.0" Z="2.6991976354079186">
<NAME>Mean baseline HbA1c&gt; 8%</NAME>
<GROUP_LABEL_1>Individual education</GROUP_LABEL_1>
<GROUP_LABEL_2>Usual care</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours individual</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours usual</GRAPH_LABEL_2>
<CONT_DATA CI_END="-0.06010392121380059" CI_START="-1.1398960787861994" EFFECT_SIZE="-0.6" ESTIMABLE="YES" MEAN_1="-1.0" MEAN_2="-0.4" ORDER="159" SD_1="0.87" SD_2="1.15" SE="0.2754622447375721" STUDY_ID="STD-Goudswaard-2004" TOTAL_1="25" TOTAL_2="29" WEIGHT="17.58256456537204"/>
<CONT_DATA CI_END="0.3073537078511556" CI_START="-0.5873537078511557" EFFECT_SIZE="-0.14" ESTIMABLE="YES" MEAN_1="-0.1" MEAN_2="0.04" ORDER="160" SD_1="1.68" SD_2="1.48" SE="0.2282458817507998" STUDY_ID="STD-Hawthorne-1997" TOTAL_1="106" TOTAL_2="86" WEIGHT="25.609463756160785"/>
<CONT_DATA CI_END="3.631443694512848E-4" CI_START="-0.6003631443694513" EFFECT_SIZE="-0.3" ESTIMABLE="YES" MEAN_1="-0.5" MEAN_2="-0.2" ORDER="161" SD_1="1.1" SD_2="0.94" SE="0.15324931822149662" STUDY_ID="STD-Ko--2004" TOTAL_1="90" TOTAL_2="88" WEIGHT="56.807971678467176"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2008-11-21 12:26:16 +0100" MODIFIED_BY="Bernd Richter" NO="2">
<NAME>Individual diabetes education programme versus group education programme</NAME>
<CONT_OUTCOME CHI2="0.07280616686332703" CI_END="1.285746539834537" CI_START="0.34373262068953525" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.8147395802620361" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2008-11-21 12:26:00 +0100" MODIFIED_BY="Bernd Richter" NO="1" P_CHI2="0.7872939878665094" P_Q="1.0" P_Z="6.981328926039022E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="78" TOTAL_2="70" UNITS="" WEIGHT="100.0" Z="3.390311335404103">
<NAME>HbA1c: 6 - 9 months (r = 0.75)</NAME>
<GROUP_LABEL_1>Individual education</GROUP_LABEL_1>
<GROUP_LABEL_2>Group Education</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.2249337454876" CI_START="-1.0249337454876" EFFECT_SIZE="1.1" ESTIMABLE="YES" MEAN_1="-3.9" MEAN_2="-5.0" ORDER="162" SD_1="3.25" SD_2="4.68" SE="1.084169792021081" STUDY_ID="STD-Campbell-1996" TOTAL_1="29" TOTAL_2="27" WEIGHT="4.9131934206786765"/>
<CONT_DATA CI_END="1.283022312935541" CI_START="0.3169776870644592" EFFECT_SIZE="0.8" ESTIMABLE="YES" MEAN_1="-1.7" MEAN_2="-2.5" ORDER="163" SD_1="1.19" SD_2="1.17" SE="0.24644448405458425" STUDY_ID="STD-Rickheim-2002" TOTAL_1="49" TOTAL_2="43" WEIGHT="95.08680657932132"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.05382508208975893" CI_END="0.07745373514317119" CI_START="-0.017645791057226155" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.029903972042972515" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2008-11-21 11:50:54 +0100" MODIFIED_BY="Bernd Richter" NO="2" P_CHI2="0.8165362040896542" P_Q="1.0" P_Z="0.21771822918672445" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="58" TOTAL_2="54" UNITS="" WEIGHT="100.0" Z="1.232618300861186">
<NAME>HbA1c: 12 - 18 months</NAME>
<GROUP_LABEL_1>Individual Education</GROUP_LABEL_1>
<GROUP_LABEL_2>Group Education</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours individual</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours group</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.48744612862058" CI_START="-3.0874461286205794" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="-3.3" MEAN_2="-3.0" ORDER="164" SD_1="4.5" SD_2="4.8" SE="1.4221925252747494" STUDY_ID="STD-Campbell-1996" TOTAL_1="25" TOTAL_2="19" WEIGHT="0.029099380917427815"/>
<CONT_DATA CI_END="0.07755668295380617" CI_START="-0.01755668295380612" EFFECT_SIZE="0.030000000000000027" ESTIMABLE="YES" MEAN_1="-0.49" MEAN_2="-0.52" ORDER="165" SD_1="0.1" SD_2="0.1" SE="0.024264059609731197" STUDY_ID="STD-Dalmau-2003" TOTAL_1="33" TOTAL_2="35" WEIGHT="99.97090061908257"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.06959720052114926" CI_END="1.4684720051001423" CI_START="0.1861531320666232" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.8273125685833828" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2008-11-21 12:26:05 +0100" MODIFIED_BY="Bernd Richter" NO="3" P_CHI2="0.791924165659473" P_Q="1.0" P_Z="0.011438262723516697" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="78" TOTAL_2="70" UNITS="" WEIGHT="100.0" Z="2.529016569092278">
<NAME>HbA1c: 6 - 9 months (r = 0.25)</NAME>
<GROUP_LABEL_1>Individual Education</GROUP_LABEL_1>
<GROUP_LABEL_2>Group Education</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.2249337454876" CI_START="-1.0249337454876" EFFECT_SIZE="1.1" ESTIMABLE="YES" MEAN_1="-3.9" MEAN_2="-5.0" ORDER="166" SD_1="3.25" SD_2="4.68" SE="1.084169792021081" STUDY_ID="STD-Campbell-1996" TOTAL_1="29" TOTAL_2="27" WEIGHT="9.104189527794246"/>
<CONT_DATA CI_END="1.4725028131220692" CI_START="0.12749718687793088" EFFECT_SIZE="0.8" ESTIMABLE="YES" MEAN_1="-1.7" MEAN_2="-2.5" ORDER="167" SD_1="1.71" SD_2="1.58" SE="0.3431199850745654" STUDY_ID="STD-Rickheim-2002" TOTAL_1="49" TOTAL_2="43" WEIGHT="90.89581047220575"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.44225689235193705" CI_END="0.6469904629082308" CI_START="-0.8740955586664616" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.11355254787911537" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2008-11-21 12:26:10 +0100" MODIFIED_BY="Bernd Richter" NO="4" P_CHI2="0.5060351805049481" P_Q="1.0" P_Z="0.7698037716341442" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="87" TOTAL_2="82" UNITS="" WEIGHT="100.0" Z="0.2926315816976924">
<NAME>BMI: 6 - 9 months (r = 0.75)</NAME>
<GROUP_LABEL_1>Individual Education</GROUP_LABEL_1>
<GROUP_LABEL_2>Group education</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.8309181542793244" CI_START="-0.8309181542793244" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="-2.2" MEAN_2="-2.2" ORDER="168" SD_1="1.85" SD_2="1.87" SE="0.42394562391630697" STUDY_ID="STD-Campbell-1996" TOTAL_1="38" TOTAL_2="39" WEIGHT="83.77820744584066"/>
<CONT_DATA CI_END="1.1883146302709875" CI_START="-2.5883146302709874" EFFECT_SIZE="-0.7" ESTIMABLE="YES" MEAN_1="-1.5" MEAN_2="-0.8" ORDER="169" SD_1="4.99" SD_2="4.25" SE="0.9634435352719602" STUDY_ID="STD-Rickheim-2002" TOTAL_1="49" TOTAL_2="43" WEIGHT="16.22179255415934"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.296726346387064" CI_END="0.7263264115983987" CI_START="-0.7452392391680303" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.00945641378481578" ESTIMABLE="YES" I2="22.88272673828231" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2008-10-28 10:26:49 +0100" MODIFIED_BY="Bernd Richter" NO="5" P_CHI2="0.2548121792508379" P_Q="1.0" P_Z="0.9799035638774328" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="63" TOTAL_2="60" UNITS="" WEIGHT="100.00000000000001" Z="0.025189811180349218">
<NAME>BMI: 12 - 18 months (r = 0.75)</NAME>
<GROUP_LABEL_1>Individual Education</GROUP_LABEL_1>
<GROUP_LABEL_2>Group Education</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.654790311899921" CI_START="-1.8547903118999212" EFFECT_SIZE="-0.6000000000000001" ESTIMABLE="YES" MEAN_1="-2.0" MEAN_2="-1.4" ORDER="170" SD_1="2.19" SD_2="2.5" SE="0.6402109027500235" STUDY_ID="STD-Campbell-1996" TOTAL_1="30" TOTAL_2="25" WEIGHT="34.38404597609065"/>
<CONT_DATA CI_END="1.2083326444176974" CI_START="-0.6083326444176974" EFFECT_SIZE="0.30000000000000004" ESTIMABLE="YES" MEAN_1="-0.6" MEAN_2="-0.9" ORDER="171" SD_1="1.91" SD_2="1.91" SE="0.46344353854586584" STUDY_ID="STD-Dalmau-2003" TOTAL_1="33" TOTAL_2="35" WEIGHT="65.61595402390937"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.03528820934807238" CI_END="12.318978826715522" CI_START="-4.08569573209149" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="4.116641547312017" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.06" MODIFIED="2008-11-12 17:37:21 +0100" MODIFIED_BY="Bernd Richter" NO="6" P_CHI2="0.8509930764371217" P_Q="1.0" P_Z="0.32527324699656557" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="49" TOTAL_2="46" UNITS="" WEIGHT="100.0" Z="0.983679272766939">
<NAME>Systolic blood pressure: 12 - 18 months</NAME>
<GROUP_LABEL_1>Individual education</GROUP_LABEL_1>
<GROUP_LABEL_2>Group education</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="23.115927390857394" CI_START="-11.91592739085739" EFFECT_SIZE="5.6000000000000005" ESTIMABLE="YES" MEAN_1="-6.8" MEAN_2="-12.4" ORDER="172" SD_1="23.2" SD_2="22.55" SE="8.936861865330583" STUDY_ID="STD-Campbell-1996" TOTAL_1="16" TOTAL_2="11" WEIGHT="21.928502490106183"/>
<CONT_DATA CI_END="12.98306451258296" CI_START="-5.583064512582961" EFFECT_SIZE="3.6999999999999993" ESTIMABLE="YES" MEAN_1="-6.4" MEAN_2="-10.1" ORDER="173" SD_1="19.52" SD_2="19.52" SE="4.73634443581953" STUDY_ID="STD-Dalmau-2003" TOTAL_1="33" TOTAL_2="35" WEIGHT="78.07149750989382"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.19668401259436408" CI_END="7.111808469351016" CI_START="-4.0682815058345065" CI_STUDY="95" CI_TOTAL="95" DF="1.0" EFFECT_MEASURE="MD" EFFECT_SIZE="1.5217634817582544" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.07" MODIFIED="2008-11-21 12:26:16 +0100" MODIFIED_BY="Bernd Richter" NO="7" P_CHI2="0.6574108442921189" P_Q="1.0" P_Z="0.593648812035206" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="49" TOTAL_2="46" UNITS="" WEIGHT="100.00000000000001" Z="0.5335559237634777">
<NAME>Diastolic blood pressure: 12 - 18 months (r = 0.75)</NAME>
<GROUP_LABEL_1>Individual education</GROUP_LABEL_1>
<GROUP_LABEL_2>Group education</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="9.501475061602289" CI_START="-10.101475061602287" EFFECT_SIZE="-0.2999999999999998" ESTIMABLE="YES" MEAN_1="-5.3" MEAN_2="-5.0" ORDER="174" SD_1="12.0" SD_2="13.27" SE="5.000844474140888" STUDY_ID="STD-Campbell-1996" TOTAL_1="16" TOTAL_2="11" WEIGHT="32.527278453398"/>
<CONT_DATA CI_END="9.205361330689659" CI_START="-4.40536133068966" EFFECT_SIZE="2.4" ESTIMABLE="YES" MEAN_1="-3.4" MEAN_2="-5.8" ORDER="175" SD_1="14.31" SD_2="14.31" SE="3.472186930152534" STUDY_ID="STD-Dalmau-2003" TOTAL_1="33" TOTAL_2="35" WEIGHT="67.47272154660202"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-002.08" MODIFIED="2008-10-31 16:51:02 +0100" MODIFIED_BY="Bernd Richter" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="NO" TOTAL_1="23" TOTAL_2="19" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Total cholesterol: 12 - 18 months</NAME>
<GROUP_LABEL_1>Individual education</GROUP_LABEL_1>
<GROUP_LABEL_2>Group education</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4629858704884223" CI_START="-0.5429858704884224" EFFECT_SIZE="-0.04000000000000001" ESTIMABLE="YES" MEAN_1="0.12" MEAN_2="0.16" ORDER="176" SD_1="0.96" SD_2="0.7" SE="0.2566301597661542" STUDY_ID="STD-Campbell-1996" TOTAL_1="23" TOTAL_2="19" WEIGHT="0.0"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2008-10-31 15:20:00 +0100" MODIFIED_BY="Bernd Richter">
<FIGURE FILENAME="colagiuri_flow_chart.jpg" FILE_TYPE="JPG" ID="FIG-01" MODIFIED="2008-10-31 15:20:00 +0100" MODIFIED_BY="Bernd Richter" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Amended QUOROM (quality of reporting of meta-analyses) flow-chart of study selection</P>
</CAPTION>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-10-31 12:52:38 +0100" MODIFIED_BY="Bernd Richter">
<APPENDIX ID="APP-01" MODIFIED="2008-10-31 12:52:38 +0100" MODIFIED_BY="Bernd Richter" NO="1">
<TITLE MODIFIED="2008-08-13 11:07:29 +0200" MODIFIED_BY="[Empty name]">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2008-10-31 12:52:38 +0100" MODIFIED_BY="Bernd Richter">
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>Search terms</P>
</TH>
</TR>
<TR>
<TD>
<P>Unless otherwise stated, search terms are free text terms; MeSH = Medical subject heading (Medline medical index term); exp = exploded MeSH; the dollar sign ($) stands for any character(s); the question mark (?) = to substitute for one or no characters; tw = text word; pt = publication type; sh = MeSH; adj = adjacent.</P>
<P>1. exp Education/<BR/>2. exp Health Education/<BR/>3. exp Health Promotion/<BR/>4. exp Learning/<BR/>5. exp Counseling/<BR/>6. exp Health Behavior/<BR/>7. exp Community health services/<BR/>8. or/1-7<BR/>9. (individual$ or one-on-one or one-to-one or standard care).tw.<BR/>10. (self$ adj6 (care or efficac$ or manag$ or monitor$)).tw.<BR/>11. exp Patients/<BR/>12. or/9-11<BR/>13. 8 and 12<BR/>14. exp Patient Education/<BR/>15. ((patient$ or adult$ or client$ or participant$ or individual$) adj3 (train$ or educat$ or teach$ or instruct$ or inform or counsel$ or empower$)).tw.<BR/>16. 14 or 15<BR/>17. 13 or 16<BR/>18. exp Diabetes Mellitus, Type 2/<BR/>19. exp Insulin Resistance/<BR/>20. glucose intoleranc$.tw.<BR/>21. impaired glucose toleranc$.tw.<BR/>22. insulin$ resistanc$.tw.<BR/>23. (exp Obesity/ or obes$.tw.) and (Diabetes mellitus/ or diabete$.tw.)<BR/>24. (obes$ adj diabet$).tw.<BR/>25. dm2.tw.<BR/>26. NIDDM.tw.<BR/>27. (non insulin$ depend$ or noninsulin$ depend$ or noninsulin?depend$ or non insulin?depend$).tw.<BR/>28. ((typ$ 2 or typ$II or typ$ ii) adj diabet$).tw.<BR/>29. ((keto?resist$ or non?keto$) adj diabet$).tw.<BR/>30. ((adult$ or matur$ or late or slow or stabl$) adj diabet$).tw.<BR/>31. (insulin$ defic$ adj relativ$).tw.<BR/>32. pluri?metabolic$ syndrom$.tw.<BR/>33. or/18-32<BR/>34. exp Diabetes Insipidus/<BR/>35. diabet$ insipidus.tw.<BR/>36. 34 or 35<BR/>37. 33 not 36<BR/>38. 17 and 37<BR/>39. randomized-controlled trial.pt.<BR/>40. controlled-clinical trial.pt.<BR/>41. randomized-controlled-trials.sh.<BR/>42. random allocation.sh.<BR/>43. double-blind method.sh.<BR/>44. single-blind method.sh.<BR/>45. or/39-44<BR/>46. animals.sh.<BR/>47. humans.sh.<BR/>48. 46 not 47<BR/>49. 45 not 48<BR/>50. clinical trial.pt.<BR/>51. exp Clinical Trials/<BR/>52. (clinic$ adj25 trial$).tw.<BR/>53. ((singl$ or doubl$ or trebl$ or tripl$) adj (mask$ or blind$)).tw.<BR/>54. placebos.sh.<BR/>55. placebo$.tw.<BR/>56. random$.tw.<BR/>57. research design.sh.<BR/>58. (latin adj square).tw.<BR/>59. or/50-58<BR/>60. 59 not 48<BR/>61. 60 not 49<BR/>62. exp Evaluation Studies/<BR/>63. follow-up studies.sh.<BR/>64. prospective studies.sh.<BR/>65. (control$ or prospectiv$ or volunteer$).tw.<BR/>66. cross-over studies.sh.<BR/>67. or/62-66<BR/>68. 67 not 48<BR/>69. 68 not (49 or 61)<BR/>70. 49 or 61 or 69<BR/>71. exp Meta-Analysis/<BR/>72. exp "Review Literature"/<BR/>73. meta-analysis.pt.<BR/>74. review.pt.<BR/>75. or/71-74<BR/>76. letter.pt.<BR/>77. comment.pt.<BR/>78. editorial.pt.<BR/>79. historical-article.pt.<BR/>80. or/76-79<BR/>81. 75 not 80<BR/>82. ((systematic$ or quantitativ$ or methodologic$) adj (review$ or overview$)).tw.<BR/>83. meta?anal$.tw.<BR/>84. (integrativ$ research review$ or research integration$).tw.<BR/>85. quantitativ$ synthes$.tw.<BR/>86. (pooling$ or pooled analys$ or mantel$ haenszel$).tw.<BR/>87. (peto$ or der?simonian$ or fixed effect$ or random effect$).tw.<BR/>88. or/82-87<BR/>89. 81 or 88<BR/>90. limit 89 to human<BR/>91. 70 or 90<BR/>92. 38 and 91<BR/>
</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>